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Abstract
6-lactoglobulin (BLG) is the major whey protein in ruminants and is
found in the milk of a wide range of species. Extensive study of
BLG over the years has led to the determination of the structure of
the protein at 2.8A and has revealed its ability to bind a variety
of small hydrophobic molecules. However, the physiological
function of BLG remains unknown despite its inclusion within the
lipocalycin family on the grounds of genetic and tertiary structure
comparisons as well as similarities in amino acid sequence.
A protein engineering approach was adopted to study the residues
involved in subunit interactions and ligand binding as well as the
importance of Cysll9 and 121 in determining the stability of the
tertiary structure.
The complete coding sequence for ovine BLG was obtained and a
convenient site-directed mutagenesis system was set up. An
expression system in the yeast Saccharomyces cerevisiae was
developed in which ovine BLG was synthesised and secreted into the
growth medium. Secretion was directed using the native BLG leader
sequence. N-terminal sequencing of the secreted protein showed
that the excision of the signal peptide occurred at the same site
observed in vivo. Four mutant forms of the protein were generated.
Cysll9 and Cysl21 were replaced with serine as separate mutants.
Ile29, one of the residues at the subunit interface, was replaced
with aspartate, and Lys70, located at the entrance to the
hydrophobic pocket, was replaced with asparagine. All mutants,
apart from 119, were secreted into the medium. Mutant 119 was
detected in cellular extracts by Western analysis. This suggested
that loss of the disulphide bridge between Cysl06 and 119
sufficiently altered the structure of the protein to inhibit its
passage through the secretory pathway. Although approximately 6-
8mg of BLG were secreted per litre of yeast culture, further
optimisation of the purification scheme was required to enhance
yields. Consequently, only preliminary characterisation of the
proteins was performed. Molecular weight determination using




B-lactoglobulin (BLG) was first discovered in bovine milk more than
50 years ago, and it represents the major whey protein component in
all the milks in which it is found. Milk is a substance rich in
lipids, proteins, vitamins and minerals and provides essential
nutritional requirements for newborn suckling mammals and
marsupials. It is also a means of providing passive immunity in
some species, eg artiodactyls, in which the newborn lack
circulating antibodies. However, in many species where passive
immunity is acquired through the placenta, eg rodents and. primates,
milk from these species still contains high concentrations of
immunoglobulins which probably serve as an additional supplement.
Milk can vary in content and concentrations of particular
constituents depending upon the species, diet, health state of the
animal and the time leading up to and after parturition.
The mechanism of milk secretion in mammals is well understood [1].
Milk is produced by epithelial cells that line the mammary alveoli
and is stored in the alveolar lumina adjacent to these cells.
There are five distinct pathways for the secretion of milk
components.
1) Exocytosis of milk specific proteins and lactose from Golgi-
derived vesicles.
2) Secretion of ions and water across the plasma membrane.
3) Secretion of fat via the milk fat globule.
4) Pinocytosis from the blood supply followed by exocytosis from
the cell eg. immunoglobulins.
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5) The paracellular pathway for plasma components and leucocytes.
Milk, therefore, contains ingredients that are either specifically
synthesised in the mammary gland, derived from the blood supply, or
accidently incorporated by the processes controlling the previous
two. The biological function of many milk constituents has been
determined, with one major exception. BLG, with a yield of between
2-4g per litre in bovine milk [2] , is the major whey protein in a
wide variety of animals. Although its properties have been
extensively studied using a wide variety of techniques since its
first isolation in 1934 [3], its biological function has yet to be
determined.
1.1 Expression of BLG
BLG is thought to be expressed from a single copy gene in ruminants
[4]. The ovine gene is composed of seven exons, the seventh exon
being totally non coding [5]. The mature transcript from this
gene, about 800 nucleotides long and representing up to 5% of the
total mENA in the mammary gland, produces a polypeptide 180 amino
acids long [6]. This Pre-BLG polypeptide comprises the 162 amino
acid mature polypeptide and the 18 amino acid signal peptide which
directs the protein into the cell secretory pathway prior to being
excised in the endoplasmic reticulum. Bovine BLGs are not normally
subject to further post-translational modification as shown by the
absence of glycosylation, even though there is a potential N-
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glycosylation site, Asn-X-Thr, at Asnl52. However, BLG from the
Australian Droughtmaster breed of cattle is glycosylated at Asn-28
[7], the residues at this position from other variants being Asp.
The levels of mRNA coding for the six main milk proteins, ocsl-,
Ocs2-, B-, k-casein, BLG, and OC-lactalbumin, have been studied
during the normal development of the mammary gland in sheep [6,8].
At mid-pregnancy, there are high levels of BLG mRNA which increase
approximately 20 fold by day 20 of lactation. Casein mRNAs can
barely be detected at mid-pregnancy and levels only increase slowly
over the same time period, albeit in a coordinated fashion.
Results have shown that although expression from all these genes
can be induced by prolactin, and the levels modulated by
glucocorticoids, eg. Cortisol, BLG mRNA expression is regulated
independantly from the casein genes.
1.2 Genetic variation and distribution
BLG from bovine milk was the first BLG to be characterised in
detail. The puzzle concerning the heterogeneous nature of BLG
crystals grown from supposedly pure protein was solved when BLG was
found to consist of two variants that differed in electrophoretic
mobility under nondenaturing conditions at pH 8.6 [9]. Since then,
further research relying on starch gel electrophoresis, amino acid
analysis and reactivity with anti-BLG antisera has not only
revealed the presence of other bovine variants but has shown that




Ten different BLG variants have so far been isolated from bovine
milk. Initially detected by their altered electrophoretic
mobilities, the amino acid differences between nine of the variants
have either been determined by sequencing or as a result of amino
acid analysis of peptide digests. A comparison of the amino acid
sequence variations of bovine BLGs are shown in figure 1.0.
Individual cows can be homozygous for a particular variant or
heterozygous. Since the variant BLG genes are expressed
codominantly [ 4 ] , heterozygous cows produce equal amounts of both
variants in their milk. A and B variants are the most common. The
C variant has only been isolated from Jersey cattle [15] and the D
variant from two individuals of the Simmenthal breed [16]. E, F
and G variants have all been isolated from Bali cattle (Banteng
oxen) [12]. The E variant appears to have the same amino acid
composition as the BLG from yak's milk [12] and another variant, W,
recently isolated from a rare breed of Bavarian cattle, Murnau-
Werdenfelder, has an electrophoretic mobility very close to that of
the B variant but has been shown to differ by a single isoleucine
to leucine substitution at position 56 [14,17]. Preliminary
characterisation by amino acid analysis of another recently
isolated bovine BLG, BLG H, has shown this particular variant to
have the highest number of exchanges so far detected within the
group [18], however, these results may not be reliable.
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Figure 1.0 Variations in the amino acid sequences of bovine
BLGs relative to BLG-B
28 45 50 56 59 64 78 118 129/30 158 ref
BOV A D E P I Q D I V D E [10]
BOV B D E P I Q G I A D E [10]
BOV C D E P I H G I A D E [2]
BOV D D Q P I Q G I A D E [11]
BOV E D E P I Q G I A D G [12]
BOV F D E S I Q G I A D<->Y G [12]
BOV G D E P I Q G M A D G [12]
BOV Dr N E P I Q D I V D E [13]
BOV W D E P L Q G I A D E [14]
Numbers show the position of the amino acid substitutions which
are highlighted in bold text.
D<->Y shows that the substitution of aspartate by tyrosine occurs
at either position 129 or 130.
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Genetic polymorphism is exhibited among other ruminants. There are
three ovine variants, A,B and C [19,6,20]. A and C variants have
Tyr residues at position 20 where the B variant consists of His and
A and B variants have Arg at position 148 where the C variant
consists of a Gin. The B variant is identical to the only BLG so
far isolated from mouflon [21]. BLGs isolated from buffalo and
goat milk also appear to be homogeneous [22,23] whereas two
variants have been isolated from pooled milk samples from red deer
which have a more acid isoelectric point than bovine A and B
variants [24].
1.2.2 Non-ruminant BLGs
Sedimentation equilibrium ultracentrifugation studies have shown
that all ruminant BLGs exist as dimers at physiological pH and
temperature, whereas those from non ruminants tend to be monomeric.
Monomeric BLGs from horse, dog, dolphin, cat and pig have all been
isolated and all exhibit genetic polymorphism. Feline milk may
contain as many as twelve BLG variants [25]. These BLGs appear to
be products from three separate gene loci each with its own allelic
variations. An individual lactating female could quite possibly
have as many as six different BLG variants in its milk. N-terminal
sequence comparisons of three of the variants with bovine and
equine BLGs have confirmed their membership within the family. The
complete amino acid sequence for feline BLG II has recently been
determined [26] which showed a 54% identity with bovine B and 68%
with the recently revised horse II [26]. Horse has two variants
both of which have been fully sequenced [27,28]. They share
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limited amino acid identity, only 113 out of 162 amino acids, and
horse II is four amino acids longer. However, the recently revised
sequence for horse II showed that this protein was only 163 amino
acids long and shared only 109 out of 162 residues with horse I.
The presence of three feline gene loci and the two equine variants
have probably arisen from gene duplication events. Analysis of the
whey proteins from dolphin, dog and manatee have shown that dog and
dolphin possess two variants and manatee one [29]. N-terminal
regions of several of these variants have been sequenced and an
incomplete primary structure of dolphin BLG A has been determined
[30]. Donkey BLG [31] and dimeric kangeroo BLG [32] have been
fully sequenced and appear homogeneous whereas pig has at least
three variants, A,B and C [33,34], one of which has been fully
sequenced [35]. Lack of cross reactivity against anti-bovine
antiserum [35,36] suggests that pig BLG is structurally distinct
from its bovine counterpart. However, this may reflect a general
trend in which antisera raised against monomeric and dimeric forms
fail to cross react, although feline BLG was detected by both horse
and bovine antisera [25].
1.2.3 Animals lacking BLG
There is strong evidence that milk from rodents, llamas and humans
do not contain BLG. An immunological search for BLG among
artiodactyls, and other orders was carried out using anti-bovine
BLG antiserum [37]. This studv failed to detect BLG from primates
and rodents among others. However, it also failed to detect BLG in
pig whey, a species in which BLG is now known to exist. These
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results therefore, cannot be used as conclusive evidence that these
animals lack BLG in their milk owing to the fact they may possess
monomeric BLGs which may not be detected by an anti-"dimeric"
antiserum. The major whey protein in rats and mice is a cysteine
rich, acidic protein with a molecular mass of 14kDa called whey
acidic protein. Whey acidic protein has been fully sequenced and
shows no sequence similarity to BLG [38]. The major whey proteins
of guinea pig and llama have all been isolated and identified with
other common milk proteins eg. serum albumin and lactalbumin. None
correspond to BLG [39,40]. The evidence concerning the presence of
a human BLG has been more contradictory. Initially, human milk
samples were found to react with anti-bovine BLG antisera,
following which, a protein with a molecular mass of 13.5kDa and a
pi of approximately 5.1 was isolated and was thought to correspond
to human BLG [41,42]. Further fractions with a molecular mass of
18kDa were found to react with an anti-bovine BLG antiserum, with
the amino acid composition of one of these being in relatively good
aggreement with that of pig BLG [43]. However, later studies
regarding the purification of immunoreactive proteins revealed a
cross reactivity with human lactoferrin [44,45], It has also been
shown by radioimmunoassays [46] and Immunoelectrophoresis [45] that
dietary bovine BLG ingested by human lactating females is
accumulated in the mammary gland and secreted into milk. It is not
clear at present whether this BLG is intact or present as
fragments, or whether there is a specific uptake mechanism in the
mammary gland or some general accumulation from the serum.
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From the comparison of sequences in figure 1.1, it can be seen that
the strongest similarity between mammal BLGs exists at the amino
end of the protein. This may have arisen through evolutionary
pressure to maintain sequences important in the putative ligand
binding site or sequences involved in receptor recognition.
Addition of the more evolutionary distant species, kangaroo, shows
that it does not have the conserved N-terminal region. . Figure 1.2
shows the percentage of amino acid identity among BLGs from
different animals. It is interesting to note that the average
amino acid identity between ruminant BLGs is approximately 98%
(this figure does not take allelic variations into account) whereas
that for non-ruminant mammals currently stands at around 61%.
Apart from the gross variations in amino acid sequences, non-
ruminant BLGs are also slightly heterogeneous in size. One can
only question whether the different nutritional requirements of
each species reflects alternative but similar ligands carried by
BLG or whether BLGs from all species carry the same ligand and the
protein sequences have diversified as a result of different
selective pressures. The function of BLG is likely to be important
otherwise the protein would not be maintained in such a wide
variety of animals. Animals that lack BLG may either use another
mechanism to provide the same function in milk or use an
alternative route and/or mechanism eg. through the placenta. It is
also possible that these animals have no need for this particular
function of milk which might reflect a major difference in
embryonic development. A human BLG analogue, placental protein 14,
is expressed in the secretory endometrium and decidua during the
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=> match across all sequences
=> conservative substitutions
=> gaps in the alignment arising from deletions or insertions not
shared by all sequences
Figure 1.1 Alignment of BLG sequences using the clustal program.
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ov mou gt buf bov pig don hoi ho2
ov 100 99.4 99.4 97.5 96.3 61.6 50.6 56.8 49.-!
mou 100 98.8 96.9 95.7 62.3 51.2 57.4 50.C
gt 100 97.5 96.3 61.4 50,6 56.8 49.<
buf 100 98.8 63.5 50.6 56.8 49.<
bov 100 62.9 50.6 57.4 49.'
pig 100 44.0 52.2 44.(





















bov = bovine B
pig = pig I
don = donkey I
hoi = horse I
ho2 = horse II
fel = feline II
kan = kangaroo
numbers = percentage of amino acid identity
average amino acid identity among ruminants =97.7%
average amnio acid identity among non-ruminant mammals =60.6%
Figure 1.2 Amino acid identity of BLGs from different animals.
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nucleic acid hybridisation has shown that no other tissues
synthesise the protein [47]. The cDNA encoding the complete 180
amino acid precursor has been fully sequenced [47] and the deduced
mature polypeptide, 162 amino acids long, shares a 53% amino acid
identity with horse BLG1, but unlike most BLGs, this protein is
glycosylated [48]. Levels of placental protein 14 in the serum are
highest between 6-12 weeks after fertilisation, whereas levels in
the amniotic fluid are highest between 12-20 weeks [48]. This may
suggest the presence of a specific transport pathway through the
placenta to the developing embryo rather than allowing the protein
to enter the general circulation of the mother. It is unlikely
that the requirements for a developing human embryo during the
first trimester supplied by placental protein 14 reflect those of a
developed newborn calf so there can be no suggestion that placental
protein 14 serves the same function as BLG. Like BLG, the function
of placental protein 14 is unknown.
At the moment, the list of animals containing BLG in their milk is
quite small but this is likely to increase with time as the search
for BLG and BLG homologues gains momentum.
1. 3 Isolation of BLG
Over the years BLG has undergone a battery of physico-chemical
studies using a wide variety of techniques. BLG has been used as a
general protein model to explain fundamental questions concerning
the roles amino acids play in determining protein structure. As a
result, large amounts of data have been compiled on the properties
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of the protein which might give a clue to its physiological
function. The extensive study of the protein has stemmed from the
fact that BLG can be easily purified in large quantities from an
almost limitless source.
Modern commercial preparations of BLG are based on a relatively
simple technique developed by Aschaffenburg and Drewry [49].
Sodium sulphate is added to whole, or preferably skimmed, milk to
precipitate fats, globulins and caseins among others, which are
removed by filtration. The pH of the filtrate is reduced to 2 with
concentrated acid causing rapid precipitation of protein
constituents apart from BLG. The precipitate is removed by
filtration and the pH of the supernatant is increased to around 6.
BLG is precipitated by the additon of more sodium sulphate.
Extensive dialysis of this resuspended precipitate against water
eventually yields BLG crystals. This procedure was an improvement
over the one developed by Palmer [3] where crystals formed from the
"lactalbumin" fraction only after exhaustive dialysis at pH 5.2.
Further improvements to the Aschaffenburg and Drewry method have
been developed [50] where ammonium sulphate has been used as the
precipitating salt. This avoids the careful temperature control
required with sodium sulphate which has a tendancy to crystalise in
whey solutions at lower temperatures. This method also reduces the
effect of local pH excesses by using dilute acid and alkali and by
increasing the pH of the acid precipitation step from 2 to 3.5.
There are other isolation methods that do not rely on an initial
acid precipitation step. Calcium chloride precipitation of caseins
from skimmed bovine milk followed by dialysis, ion exchange
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chromatography and gel filtration eventually yielded BLG crystals
that diffracted better than those obtained following acid
precipitation procedures [51]. Poorer diffraction from the earlier
crystals possibly resulted from damage induced by the harshness of
the acidic step. Another slight variation involving an acid
precipitaion step at pH 4.6 to remove fats and caseins was used to
isolate dolphin and manatee BLG [29]. Subsequent gel filtration
followed by ion exchange chromatography provided BLG pure enough
for amino acid sequencing.
1.4 Characterisation of BLG
Most studies have involved bovine BLG and all references to protein
behaviour will concern BLG from this species unless otherwise
specified.
1.4.1 Alterations in behaviour and molecular mass with pH
Variations in the molecular mass of BLG have been obtained using
different procedures. Sedimentation equilibrium analysis has
yielded values of 39kDa [52] and 35.6kDa [53], values obtained by
osmotic pressure, 35.05kDa [54], and studies involving hydration of
protein crystals have led to values of 35.8kDa in dry crystals
[55]. However, it was shown that BLG undergoes rapid and
reversible dissociation below pH 3.5, a reaction which is thought
to involve both electrostatic and hydrophobic interactions. Light
scattering measurements showed that both dissociation products had
an approximate molecular mass of 18kDa [56]. This was supported by
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a value of 17.1kDa obtained from surface films of BLG spread over
concentrated ammonium sulphate solutions but this value increased
to 34.3kDa in the presence of Cu2+ ions [57]. SDS-PAGE and amino
acid analysis [58] showed the molecular masses to approximate
18.3kDa. Thus, the classsically defined protein with a molecular
mass of 36kDa consists of two identical subunits of 18kDa which
only dissociate into their monomer state at low pH.
An interesting behavioural phenomenon with one bovine variant was
observed between pH 3.7 and 5.2 [59,60,61]. BLG A polymerises at
low temperatures to form 144kDa octamers, or perhaps more
accurately, tetramers of the dimeric form of BLG. Neither B nor C
variants form appreciable aggregates over this pH range although
polymerisation of A and B mixtures has been detected. The reaction
is rapid and reversible but no appreciable amounts of aggregation
intermediates were discovered. No larger aggregates were detected
suggesting the formation of distinct structures rather than linear
aggregates, the further polymerisation of these structures being
possibly inhibited by steric hindrance. Carboxyl groups have been
strongly implicated in this reaction. The pK of a carboxyl group
lies within the optimal pH range of polymerisation and increased
protonation might promote intermolecular hydrogen bonding.
Modification of carboxyls with carbodiimide metho-p-toluene
sulphonate at levels that induce little change in o.r.d. profiles
with respect to the native protein greatly reduces the ability of
BLG A to polymerise [62]. However, the inhibition is not total
which suggests the involvement of other interactions. BLG A
differs from other variants by having an Asp at position 64 which
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might play an important role in this process. The Droughtmaster
variant also has an Asp at this position but does not polymerise.
This possibly arises from steric hindrance caused by the
carbohydrate moiety attached to Asn 29.
BLG is primarily dimeric between pH 3.5 and 8. At higher pH
values, the protein dissociates into monomers. The protein begins
to denature as the pH increases and is accompanied by a large
change in optical rotation [63], The rate of change is slow at pH
8.25 but increases with increasing pH which coincides with the
ionisation of amino groups. Infrared spectroscopy has shown that
the primary stages of alkaline denaturation involve the unfolding
of the cX-helix and exposed 13-strands followed by the unfolding of
core 6-strands to form a random coil structure. This rate of
unfolding is enhanced at low temperatures [64]. The onset of rapid
irreversible denaturation occurs above pH 9.5 and is thought to
involve intra and interchain disulphide interchange. Studies
showed that during prolonged incubation at pH 8.25, the free thiol
content dropped to 7% of its original value and that aggregation
was inhibited in the presence of thiol blocking agents [65]. Early
sedimentation equilibrium studies showed a small decrease in
sedimentation coefficient around pH 7.5 [52], but was not
accompanied by a loss in molecular mass [66]. Titration curves
showed the anomalous behaviour of two carboxyl groups, one per
monomer, over the same pH range [67], This unusually high pK for
carboxyl ionisation inferred that the side chain was buried within
the molecule below pH 7.5 and possibly involved in hydrogen
bonding. Since BLG undergoes slow irreversible denaturation above
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pH 8, this behaviour is possibly a result of refolding into an
alternative motif more thermodynamically stable at this pH, rather
than an unfolding of the molecule. The transition, commonly known
as the Tanford transition, is totally reversible and does not
appear to affect subunit interactions [66] (fig. 1.3).
1.4.2 Denaturation of BLG
Many denaturation studies lie outwith the normal environmental
stresses of the protein and are not directly concerned with its
physiological behaviour, although some lie within suitable ranges
of pH and temperature. They supply information about the processes
involved and whether denaturation by different means follows the
same rules. Information derived from these studies can be
important for the handling of the protein but many studies,
especially extremes of temperature, are primarily useful to the
food industry and will not be discussed here.
1.4.2.1 Effect of Temperature
Reversible conformational changes resulting from thermodenaturation
are demonstrated by the changes in the environment of the two
tryptophan residues, and occur up to and around 70°C prior to the
formation of irreversibly denatured product [68]. Prolonged
heating at 80°C followed by rapid cooling shows a similarity with
alkaline denaturation in that there is a time dependant
irreversible denaturation of the protein. This irreversible

















Figure 1.3 The Tanford transition. The diagram shows the
dependance of the specific rotation at 578nm on pH of bovine
BLG-B [178],
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tryptophans to return to their hydrophobic environments. The first
step involves the dissociation of the dimer [69]. It has also been
shown that the denaturation temperature of BLG increases in the
presence of sugars such as lactose and sorbitol [70]. Infrared
spectroscopy [63] shows that reversible changes in conformation
occur below 60°C and agrees with the similarities of alkaline
denaturation observed above since some of the spectra obtained by
both denaturation methods are superimposable. However,
thermodenatured BLG still maintains a sizeable amount of secondary
structure prior to aggregation which contrasts to the predominately
random coil structures observed in alkaline denaturation.
The protein's thermodynamic behaviour was determined from
equilibrium thermal unfolding curves derived from u.v. difference
spectroscopy [71]. The observed properties were an indication of
the strong acid stability of the protein. These investigations
showed that the transition temperature from the folded to the
unfolded state increased as the pH was lowered from 7.5 to 1.5,
below which it decreased. These results, among others, led to the
proposition of a possible mechanism for the acid stability of BLG
[71]. As the pH is lowered from 7.5 to 5.2, the protein's
isoelectric point, the loss of negative charge on the protein
surface may facilitate closer packing within the protein's interior
resulting in increased hydrophobic interactions and van der Waals
attractions. This closer packing has been observed experimentally
in which alterations in secondary structure induced by an increase
in pH from 4 to 6 have led to an increase in sedimentation
coefficient resulting from contraction of the protein [72]. As the
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pH is lowered further, the gain in net positive charge does not
result in the destabilisation of the protein. The stability of BLG
increases down to pH 1.5 which may result from the loss of
unfavourable localised electrostatic interactions as the carboxyls
are titrated, which allows the formation of new and more stable
hydrogen bonds upon protonation of the same groups.
Another important factor influencing thermodenaturation is the
hydration of the protein. Hydration is essential for stabilising
the spatial structure of proteins. Studies showed
thermodenaturation is accompanied by the loss of ordered hydration
shells around the protein with a concomitant decrease in the heat
of denaturation [73].
1.4.2.2 Organic denaturants
BLG has been denatured by a variety of organic compounds such as
urea, guanidine hydrochloride (GuHCl), alcohol and detergent.
These studies have given rise to controversies regarding the
kinetics of denaturation with individual denaturants as well as the
conformation of the denatured protein.
Urea denaturation of BLG at pH 3 appears to follow first order
kinetics which involve two major states, native and unfolded [74].
The first stage involves the complete dissociation of the BLG dimer
at a urea concentration of 3M (BLG is already considerably
monomeric at this pH). Since the major transition occurs between 4
and 6M, the native state was presumed monomeric. BLG is fully
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denatured above 8M and the whole process is completely reversible.
Other studies involving urea denaturation at pH 3.5 and 5.2 follow
more complex kinetics [75]. Denaturation can be broken down into
two parts: a rapid primary stage that is reversible and a slower
secondary stage which shows an increasing loss of reversibility
with time accompanied by a gradual increase in viscosity. The
kinetics of the refolding reaction increased in complexity with
time but the reaction was more favourable at pH 3.5 than at 5.2.
This increase in complexity was attributed to aggregation arising
from disulphide interchange since denaturation assumed first order
kinetics in the presence of N-ethylmaleimide, a thiol blocking
agent. These studies led to a sequential rather than a parallel
mechanism for unfolding. The increasing loss of solublilty in weak
salt solutions of BLG incubated for progressively longer periods in
urea before dilution has also been attributed to disulphide
interchange [76]. Denaturation studies on mixed disulphide
derivatives [77] also showed a deviation from a two state mechanism
of unfolding whereas urea gradient electrophoresis showed a rapid
two state transition at pH 7.2 [78]. Renaturing BLG gave rise to
two bands, one corressponding to native BLG, the other to a slower
refolding intermediate. This slower band was absent in BLG
denatured at pH 2 where the amount of disulphide interchange should
be negligible. These contrasting results may be balanced by
considering that two-state denaturation transitions may not hold
under all conditions [79].
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The general interpretation for the fully denatured state of BLG
denatured by urea and GuHCl, determined by o.r.d. studies, consists
of an unfolded random coil structure [80,81,82], This contrasts
with the surprising evidence obtained from c.d. analysis in which
there is a loss of C<-helix but the amount of B-sheet remains
constant even at high concentrations of denaturant [83],
Alcohol has the ability to denature BLG much in the same way as
urea and GuHCl but the reaction is not completely reversible [82],
This irreversibility is acompanied by an increase in viscosity with
time when the ethanol concentration approaches 40% v/v suggesting
aggregation has occurred. Unlike urea and GuHCl, ethanol has no
special ability to disrupt hydrogen bonds. This leads to the
formation of a structure with a high (X -helix content upon
denaturation [82,84], The formation of this helical structure does
not represent a smooth transition from B-sheet, but occurs in two
stages: unfolding of the native structure followed by refolding
into a structure with a high helical content.
SDS and other anionic detergents can affect the conformation of
BLG. At low SDS concentrations, 1 mole of BLG (dimer) binds two
moles of SDS. C.d. spectra in the far ultra-violet region showed
there did not appear to be any difference in conformation between
native BLG and the SDS-bound form [85]. Modification of cysteines
and surface tryptophans did not affect binding but it also showed
that the native conformation of the protein was not a critical
prerequisite for binding. These studies also showed that
photooxidation of BLG greatly reduced the ability of BLG to bind
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SDS. However, SDS-bound and native BLG photooxidised to the same
extent at the same rate. The nature of the binding site has not
yet been determined. At higher concentrations, 22 molecules of SDS
or n-Octylbenzene-p-sulphonate were found to bind in an "all or
nothing" fashion [86,87]. These studies suggest that although
there are two major binding sites per dimer, BLG contains many
weaker binding sites that are rapidly filled as the protein
unfolds. Increasing the detergent concentration further leads to
the formation of micellar structures arising from interactions
between the detergent bound to the protein and the detergent in
solution.
Variations in molecular mass with pH may not bear any relationship
to BLGs function in vivo, but may just reflect the physical
characteristics of pure protein in solution. However, changes in
conformation with pH may reflect important stages of the protein's
passage through the digestive system. At acidic pH values, the
protein is stable and adopts a more compact conformation. This
probably correlates with its ability to resist degradation by the
gastric conditions in the stomach. Digestion studies in rats
showed that BLG resisted degradation by gastric proteases, even
after four hours, and with a stomach pH of 3.46 [88]. BLG's
resistance to proteolytic cleavage by pepsin and gastric juices has
also been demonstrated in vi tro [ 89 ]. As BLG travels into the
small intestine, the concomitant increase in pH induces a
relaxation of the tertiary structure, and around pH 7.5, a change
in conformation known as the Tanford transition occurs. With the
proposal that BLG may function as a ligand carrier (see later), it
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is interesting to speculate that having protected the ligand during
its passage through the stomach, the protein now adopts a
conformation that allows the presentation of the ligand to its
receptor in the small intestine.
Much controversy surrounds the denaturation of BLG. It is not
surprising that BLG may denature differently in the . presence of
different denaturants, ie. alterations in the kinetics of
denaturation or the amount of remaining secondary structure.
However, its is unlikely variations arise using a single denaturant
unless the reaction conditions vary. It is not clear at present
whether denaturation by urea is a two step process or whether
denaturation is mediated by the formation of intermediates.
Further study is required.
1.5 Structure and function of BLG
There is no direct evidence regarding the physiological function of
BLG. The protein has no apparent enzyme activity, and purification
procedures have never led to the isolation of a specific ligand.
This may be a reflection of the harshness or unsuitability of the
procedures used. Proposed functions have relied on circumstantial
evidence centering on similarities with other proteins at three
levels:
A) tertiary structure,
B) organisation of the encoding genes and
C) amino acid sequence.
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1.5.1 Structure of BLG
Early studies by i.r. spectroscopy showed that BLG had a tightly
folded secondary structure with a large amount of B-sheet and
possibly a small amount of CX-helix [90]. C.d. studies showed the
protein comprised approximately 10% OC-helix with the rest of the
structure being divided equally between B-sheet, possibly anti-
parallel in nature, and random coil [91]. This was in rough
aggreement with values of 15% OC-helix, 50% B-sheet and 15-20%
reverse turn obtained using secondary-structure-prediction
algorithms [92]. The true nature of the protein's structure was
only obtained with the onset of X-ray crystallography analysis.
Data obtained at a resolution of 6A showed that BLG was roughly
spherical in shape with a diameter of 28A, and that the subunits
shared a dyad related symmetry. The first detailed structure was
obtained at a resolution of 2.8A [94,95]. It consists of a
flattened barrel, closed at one end, made up from eight anti-
parallel B-strands, designated A-H, which is flanked at the C-
terminal end by a three turn OC-helix and another stretch of B-
strand, Strand I, (fig. 1.4). This structure consists of 7% 0C-
helix and 51% B-strand and varies only marginally from the data
obtained from another crystal, grown under slightly different
conditions, at a resolution of 2.5A [51]. Both structures clearly
show the presence of disulphide bridges between Cys66-160 and
Cysl06-119 with a free sulphydryl at Cysl21. This latter fact is
contested by peptide mapping experiments which show that Cysl06 can
form a disulphide bridge with both Cysll9 and 121 in equimolar
amounts [96]. The subunit interface occurs along strand I and is
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Figure 1.4 Tertiary structure of bovine BLG at 2.8A.
The B-strands are represented by green ribbons and are labelled A-
I. TheCX-helix is shown in white ribbon.
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thought to involve hydrophobic interactions between lie 29 and 147
and the stacking of imadizole rings of Hisl46 [95]. Although the
major structural elements have been clearly defined, N-terminal
and C-terminal regions as well as several loops do not have clearly
defined areas of electron density, presumably reflecting regions of
high mobility [97].
1.5.2 Structurally related proteins
Several proteins show a very close structural resemblance to BLG.
Insecticyanin is a protein that binds the chromophore biliverdin IX
and is found in the hemolymph and integument of the tobacco
hornworm. Its importance lies in the blue-green camouflage
colouration it provides in conjunction with yellow pigmentation
supplied by carotenoids. It is synthesised only in the larval
stage [98]. Insecticyanin binds the chromophore so tightly that
the protein must be denatured in order to release it [ 99 ] . The
protein has been crystalised [100] and the structure determined to
a resolution of 2.6A [101]. The structure of bilin-binding
protein, a protein isolated from white butterfly which also binds
biliverdin, has also been determined [102,103], Both structures
exhibit the flattened barrel conformation made up from eight anti-
parallel B-strands flanked on the C-terminal side by a three turn
o(-helix. The barrel, like the one in BLG, is open to solvent at
one end and closed at the other. Both proteins also possess two
disulphide bridges. It is likely that these proteins serve as
transporters for the chromophore since biliverdin is insoluble in
aqueous environments at neutral pH [102].
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The structure of serum retinol-binding protein has also been
determined to a high resolution [104,105]. Retinol-binding
protein, synthesised in hepatocytes, transports retinol from the
liver to target tissues complexed to transthyretin, formerly called
thyroxine-binding prealbumin. Having deposited retinol with the
desired cell surface receptor, the retinol-binding protein-
transthyretin complex dissociates whereupon retinol-binding protein
is degraded in the kidneys. Retinol-binding protein has three
disulphide bridges and the same barrel construction flanked by a
four turn £X-helix. Retinol-binding protein has only been
crystalised with retinol bound to it, but unlike biliverdin which
is bound to insecticyanin and bilin-binding protein in a compact
configuration [101,103], retinol found in retinol-binding protein
isolated from human plasma is the extended all-trans isomer [106].
1.5.3 Homologous proteins
Evidence regarding the membership of BLG within a particular family
of proteins can be obtained by looking for similarities in amino
acid sequence. Analysis of this kind has shown that BLG belongs to
a family of proteins collectively known as the lipocalycins which
are known to be able to bind a variety of small hydrophobic
ligands.
Members of this family include three rodent proteins that may
function as behavioural stimulants. Major urinary protein from
mouse is synthesised in the liver and secreted in the urine [107].
Other members from the same protein family are also synthesised in
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the mammary, lachrymal and submaxillary glands with each tissue
expressing its own specific pattern of mRNAs [107]. Alpha-2-
microglobulin is synthesised in the liver of male rats said excreted
into the urine [110]. Aphrodisin has been isolated from the
vaginal discharge of female hamsters and has an aphrodisiac effect
on males [111]. The levels of these proteins are under multi-
hormonal control. No active ligand has been detected with these
proteins and yet aphrodisin maintains its behavioural activity
under conditions condusive to the separation of a noncovalently
linked ligand [111].
In close connection with these proteins are others that may be
responsible for binding such elusive molecules. Rat odorant-binding
protein, bovine pyrazine-binding protein and frog Bowman's gland
protein are all exclusively associated with the nasal olfactory and
respiratory mucosa and can bind a variety of hydrophobic ligands
[112,113,114]. These proteins may help to solubilise and
concentrate odorants in the mucus and allow receptor mediated
transfer to cells in the olfactory cilia [111].
BLG has already been compared to proteins that carry chromophores
eg. retinol-binding protein and insecticyanin. Other functionally
related proteins include purpuric and crustacyanin. Chicken
purpuric is synthesised in nerve cells within the retina and is
known to bind retinol and heparin [115]. The protein is associated
with the extracellular matrix and is important for cell adhesion
and cell survival [115,116]. Crustacyanin isolated from lobster
binds the blue pigment astaxanthin [117] and may provide the same
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colour camouflage role observed in the two insect proteins.
Apolipoprotein D is a major component of high density lipoprotein
in human plasma. As well as being synthesised in the small
intestine and liver, the major source of other apolipoproteins
[118], mRNA has also been detected in the pancreas, kidney, brain
and spleen among others [119]. Various functions have been
attributed to the protein. Apolipoprotein D has been shown to bind
lecithin:cholesterol acyltransferase which catalyses the synthesis
of almost all the plasma cholesteryl esters [120]. However,
molecular modelling studies have shown that apolipoprotein D may
bind heme-related compounds similar to biliverdin [121] and other
studies have shown that it can bind progesterone [122].
Other protein members may have roles that affect the immune
response to pathogens. The polymorphic OC-l-acid glycoproteins are
abundant plasma proteins synthesised in the liver [123]. Plasma
levels increase under a variety of pathogenic conditions eg. acute
inflamation [124] and highly purified OC-l-acid glycoprotein has an
inhibitory effect on thrombin-induced platelet aggregation [125].
It also binds progesterone in a pH dependant manner at one
particular site [126] and can form interactions with over 60
different drugs [127]. The terminal complement component C8 is
involved in membrane attack resulting in cell lysis. The gamma
subunit of this complex appears to belong to the family, however,
its function has still to be ascertained since loss of this subunit
does not affect cytolysis [128]. Another heterogeneous protein,
protein HC, is found free in the cytoplasm and complexed to IgA
and/or serum albumin [129] possibly by disulphide bridging [130].
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Protein HC has been shown to inhibit the migration of neutrophils
in endotoxin-activated serum [129]. (X-l-microglobulin has an
almost identical amino acid sequence to protein HC apart from an
extension at the C-terminal tail. Both proteins contain a brown
chromophore which is covalently linked to carbohydrate moeities
[131].
The final member of the group (at the moment) is androgen-dependant
epididymis secretory protein which accounts for the major
proportion of proteins in the epidiymal luminal fluid [132]. Sperm
gradually matures as it passes through the epididymis but requires
constant androgenic support [133]. This maturation is accompanied
by the binding of several epididymis secretory proteins, one of
which has been fully sequenced [132], but the roles of these
proteins have yet to be elucidated.
The amino acid sequence relationships between the proteins can be
seen in figure 1.5. As well as the limited similarities between
adjacent proteins, the alignment shows two regions in which all or
the majority of proteins share the same amino acids. Glyl7 and
Trpl9 (BLG numbering) are conserved in all proteins apart from rat
0(-l-acid glycoprotein where Glyl7 is substituted by Asp (the human
variant is shown in the diagram). In another region, Asp98 and
Tyr99 are present in the majority. Spatially, these regions lie
around the closed end of the calyx implying they play a role in
maintaining a similar structure or are involved in ligand binding
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Figure 1.5 Regions of amino acid sequence identity within the
lipocalycin family. The proteins were aligned using the Clustal
program and the diagram shows the amino acids shared between
adjacent proteins as well as those that are highly conserved.
Residues that were not conserved or shared by adjacent proteins
(the evolutionarily most closely related proteins are adjacent to
each other) were omitted from the diagram.
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1.5.4 Gene structure
Comparisons at the level of gene organisation can be made to
provide further evidence for membership within a common family.
Comparisons of the structures of genes encoding a number of
lipocal.vcin proteins have already been made [5], however, three
have been singled out here because of their striking similarities.
The gene structures of major urinary protein [108], BLG [5] and
placental protein 14 [109] are all shown in figure 1.6. Although
all the corresponding introns vary in size, all genes consist of
seven exons with the seventh exon being totally noncoding.
Corresponding exons are similar in size. Major urinary protein and
BLG share two identically sized exons, and even more strikingly,
BLG and placental protein 14 share four. All three genes produce
mature polypeptides of 162 amino acids which are secreted from
their cells of origin.
Comparisons of the gene structures for BLG and retinol-binding
protein have shown that although retinol-binding protein comprises
only six exons, analagous exons (BLG exon2 and retinol-binding
protein exon3 and onwards) encode regions of protein that share the
same structural elements with exon5 of retinol-binding protein
being very similar to the fusion of exons5 and 6 of BLG [5].
The lipocalycin family includes proteins that have a low overall
sequence similarity although there are obvious branching regions of
shared amino acids linking them. Several members are known to
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Figure 1.6 Alignment of gene structures of PPM, BLG, and MUP.
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amino acid sequence. This may prove to be true for all members.
The proteins are all small, around 20kDa, and comprise major
components of plasma and/or other secretions. It is clear that BLG
fits into this family using these criteria. Although there is a
lack of evidence regarding the physiolgical role of many of these
proteins, many have the ability to bind small hydrophobic molecules
with varying degrees of specificity. These proteins may serve as
general carriers for small hydrophobic molecules and it is possible
that BLG has the same function.
1.5.5 Ligand binding
Since the finding that the structure of BLG closely resembles that
of RBP [94], much attention has focussed on the possible role of
BLG as a retinol carrier. The fluorescence lifetime and the
fluorescence quantum yield of retinol bound to RBP is markedly
greater than that of free retinol [141]. RBP also has the ability
to protect retinol from oxidation by alcohol dehyrogenase. The
binding of retinol to BLG produced the same effects but to a lesser
degree in all three cases [137]. Spectroscopic characterisation of
the retinol-BLG complex showed that two moles of retinol bound one
mole of BLG dimer in a noncooperative manner [142]. Binding
involved hydrophobic interactions and induced a rigidity in the
retinol molecule. X-ray structural analysis has shown that retinol
is completely enclosed within the calyx of RBP with the ionine ring
lying deepest in the pocket and the isoprene tail stretching out to
the surface [104]. Retinol has been modelled into a similar
position with BLG but the isoprene tail is more accessible to
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solvent [95] which might be a reflection on the protein's
inability to protect retinol from oxidation. Interestingly,
retinol-BLG complexes have been crystallised [51], and in this case
the retinol is not bound within the calyx, but to a hydrophobic
region on the protein exterior running parallel to the (X-helix.
The significance of this result is unclear at present.
Other evidence that BLG plays a role in retinol transport centres
on the discovery of specific receptors for retinol-BLG complexes in
the small intestine of neonate calves which do not appear to be
present in adults [95]. This carrier role for BLG may correlate
with the protein's ability to resist denaturation in the stomach.
BLG can also enhance the uptake of retinol in the jejunum of young
suckling rats [143] which is surprising since no BLG has ever been
isolated from rat milk. This result is difficult to explain unless
BLG in some way mimics the function of an indigenous rat protein
[143]. However, since retinol is mainly associated with the fat
globule [144] and no retinol-BLG complexes have ever been isolated
other than those isolated in vitro, the binding of retinol is
probably not specific but may reflect a general affinity for small
hydrophobic molecules. Studies have shown that even retinol-
binding protein can bind a variety of retinoids although only a few
complexes are able to form interactions with transthyretin [106].
Other studies have proposed that BLG may play a role in lipid
metabolism. Triglycerides are taken up from the blood to form milk
lipids in the mammary gland [145]. Gentle BLG purification
procedures have led to the detection of various free fatty acids
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and triglycerides as well as trace amounts of cholesterol and
cholesterol esters bound to the protein [146,147]. The free fatty
acids and the fatty acids that make up the lipids consist mainly of
myristic, palmitic and oleic acids with chain lengths of 14, 16 and
18 carbons respectively. These fatty acids account for the major
proportion of lipids in bovine milk. Binding involves both
electrostatic and hydrophobic interactions at one major site with
the binding affinity increasing with increasing chain length to an
optimum of 16 carbons [147,148]. Several weaker affinity sites are
also present. However, serum albumin has a much higher affinity
for lipids having as many as six high affinity sites as well as
numerous weaker ones [148]. Albumin may serve as a general
"mopping up" agent for free fatty acids since even small amounts of
free fatty acids can be harmful to cells whereas BLG, with its
weaker affinity, may facilitate their delivery to specific target
cells.
It has also been reported that BLG can inhibit the hydrolysis of
certain small phosphates by phosphoprotein phosphatase and may act
to regulate phosphate metabolism in the mammary gland [149].
Spectroscopic studies showed that BLG could bind p-nitrophenol
phosphate as well as other nitrophenyl compounds with a
stoichiometry of one mole of ligand per mole of BLG monomer [150].
Studies involving other aromatic compounds showed similarities to
the binding of free fatty acids and lipids, in that binding
occurred at one high affinity site as well as several weaker ones
[151].
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The binding of small alkanes such as butane and pentane and others
have also shown competition for a highly hydrophobic region near
the surface [152], whereas a specificity for a structure formed by
conjugated double bonds of the G-ionone ring and its isoprenoid
chain have been demonstrated during affinity studies on retinoid
related flavour compounds [153].
It has been shown that BLG can bind a variety of small hydrophobic
ligands. However, although some of these ligands are biologically
important, there is no clear evidence that BLG functions as a
specific carrier for any of them.
1.5.6 Milk protein interactions
BLG does not appear to form natural interactions with other milk
proteins although lactoferrin can form soluble complexes in vitro
in weak salt solutions [154]. It can form complexes with casein
and lactalbumin resulting from heat induced coagulation [155,156]
which creates problems for the food industry and will not be dealt
with here.
1.6 Aims and strategy of the project
BLG has been the subject of extensive chemical modification studies
in the past to answer questions regarding the particular roles of
individual amino acids and how they might affect the structure and
possibly the function of the protein. However, many modifications
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and the conditions used to attain them may themselves have
contributed to alterations in properties leading to
misinterpretation, which on occasion has led to controversy.
It was proposed to develop an expression system using yeast to
synthesise and secrete ovine BLG into the growth medium to
facilitate purification of the protein. Specific amino acid
residues would be altered by standard site-directed mutagenesis
techniques and yields would hopefully be sufficiently high to allow
full characterisation of all proteins.
Specific areas of interest lay with:
1) the amino acids involved in subunit interactions namely
Ile29,
2) residues that might have a role in ligand binding namely
Lys70
and 3) which cysteine residue is involved in forming the disulphide
bridge with Cysl06.
The long term aim of the project is to develop the protein as a
drug carrier for hydrophobic or acid labile drugs. It may be
possible to engineer the protein to bind a variety of drugs within
the hydrophobic pocket and make use of the protein's acid stability
to deliver the drug to the small intestine for absorbtion.
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2.0 Materials and methods
2.1 Materials
2.1.1 Strains
E.coli: TGI K12, A(lac-pro), supE, thi-1,
hsdDS/F'traD36, proA+B+, lacIq , lacZ AMI5.
BW313 HfrKL16 PO/45 [lysA(61-62)], dut-1, ung-1,
thi-1, relAl
S.cerevisiae: AH22 leu2-3,2-12, his4-519, canl
JRY188 MAToc., leu2-3,112, ura3-52, trpl, sir3-8,
his4, rme
DBY747 leu2-3,112, his3A, ura3-52, trpl
2.1.2 Vectors
pUC19BLG was supplied by Dr S. Harris who is currently at
Glaxo Ltd, Greenford, Middlesex.
pK18, pUC1813, pUC1318 and pBM150 were all supplied by Dr
A. Boyd from this department.
M13mpl8 and mpl9 were supplied by Bethseda Research
Laboratories (U.K.) Ltd., Cambridge, U.K.
pMA91 was supplied by Dr S. Kingsman, Dept. of
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Biochemistry, University of Oxford.
2.1.3 Growth media
Oxoid Ltd., Haverhill, Suffolk
Agar No.1, tryptone, yeast extract.
Difco Labs, Central Avenue, East Molesey, Surrey
Bactopeptone, purified agar, yeast nitrogen base without
amino acids.
Sigma Chemical Company, Poole, Dorset
Ampicillin, kanamycin, Xgal, IPTG, all amino acids and
nucleotides.
2.1.4 Enzymes
Northumbria Biologicals Ltd., South Nelson Ind. Est. Cramlington,
Northumberland
Klenow fragment, T4 polynucleotide kinase and all
restriction endonucleases.
Boeringher Mannheim, Bell Lane, Lewes, East Sussex
T4 DNA ligase and RNase A.
Amersham pic, Lincoln Place, Aylesbury, Buckinhamshire
T4 DNA polymerase, deoxyadenosine 5'(35S)






All oligonucleotides were synthesised by the OSWEL DNA service,




Hyperfilm MP X-ray film and site-directed mutagenesis kit
Cambridge Bioscience, Newton House, Devonshire, Cambridge
Sequenase™ DNA sequencing kit.
Millipore (U.K.) Ltd., Peterborough Road, Harrow, Middlesex
Millex-GS 0.22um filter units.
Schleicher and Schuel, B-3354 Dassel, Germany
Biotrap apparatus, nitrocellulose.
Bio-Rad Laboratories Ltd., Bio-Rad House, Maylands Avenue, Hemel
Hempstead, Hartfordshire.
Peroxidase labelled goat anti-rabbit antibodies.
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Sigma
Polaroid 665 film, agarose and bovine BLG standard.
A & J Beveridge Ltd., 5 Bonnington Road Lane, Edinburgh
5,15 and 50ml Falcon tubes.
All other biochemicals were supplied by Sigma and B.D.H., Poole,
Dorset, and were reagent grade or better.
2.2 Methods
2.2.1 Standard techniques
The standard experimental techniques used throughout much of this
project are described in Methods in Enzymology 1988, 152 ' Guide to
Molecular Cloning Techniques' and are listed below along with the
page numbers.
Technique page no.
Enzymic manipulation of DNA 91-144
Growth and storage of E.coli 145-151
Transformation of E.coli 151-154
Preparations of plasmids and phage 154-170
Sequencing of denatured plasmid DNA 556-562
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2.2.2 Phosphorylation of oligonucleotides for mutagenesis
The oligonucleotides supplied by the OSWEL DNA service lacked the
5' terminal phospho group. This terminal phospho group is
essential for the formation of a phosphodiester bridge during DNA
synthesis of the mutant strand (see below).
40pmol oligonucleotide lul
lOx kinase buffer lul
T4 polynucleotide kinase (3u) lul
distilled water 7ul
lOx kinase buffer: 1M Tris-HCl pH 8, lOOmM MgCl2, 70mM DTT^lOmM
ATP.
The reaction mixture was incubated at 37°C for 30 min then heated
at 70 "C for 10 min to heat inactivate the enzyme. The'
oligonucleotide could either be used directly for mutagenesis or
stored at -20°C.
2.2.3 Site-directed mutagenesis
Two different methods for oligonucleotide-directed in vitro
mutagenesis were employed in this study. Both methods required a
single stranded DNA template, bacteriophage M13, which carried the
gene to be mutated by a prior subcloning step. The life cycle of
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bacteriophage Ml3 makes it extremely useful for these procedures in
that its genome consists of a closed circular piece of DNA which
replicates by means of a double stranded intermediate.
The Kunkel procedure
The template strand is grown in the BW313 strain of E.coli which
carries the dut- and ung- mutations. The dut- mutation leads to a
deficiency in dUTPase. Since dUTP cannot be converted to dUMP,
there is an increase in the intracellular pool of dUTP which is
then occasionally incorporated in place of dTTP during DNA
synthesis. In ung+ strains, the incorporated dUTP would normally
be removed by uracil N-glycosylase, however, this strain also
carries the ung- mutation which results in the retention of
incorporated uracil. Following the annealing of the mutant
oligonucleotide and synthesis of the mutant strand in vitro, the
double stranded phage is used to infect an ung+ strain, eg. TGI.
Uracil is removed from the template strand which is then suseptible
to exonucleases resulting in the destruction of the template
strand. A new round of in vivo DNA replication should ensure that
the desired mutation is now present on both strands.
The Eckstein procedure
This method was supplied in kit form by Amersham and all protocols
were followed exactly. The protocol, briefly summarised, involves
the anealling of the mutant oligonucleotide to the single stranded
template like the procedure above. A phosphorothioate analogue of
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dCTP is incorporated into the growing mutant strand during in vitro
synthesis rendering it resistant to cutting by restriction enzymes
such as Neil. The parental strand of the heteroduplex is then
nicked by Neil making it susceptible to digestion by exonuclease
III. A second round of in vitro DNA synthesis using the mutant
strand as the template creates a homoduplex which contains the
desired mutation on both strands.
2.2.4 DNA sequencing
The dideoxy method of sequencing supplied in kit form (Sequenase™
DNA sequencing kit available from Cambridge Bioscience) was used to
sequence the wild type BLG gene and to verify the mutations
generated in M13. For the purposes of this project, gene refers to
the cDNA encoding the full length BLG polypeptide. The use of
Sequenase™, a modified T7 DNA polymerase, allowed extended





(200mM Tris.HCl pH 7.5, lOOmM MgCla, 250mM NaCl) 2ul




To previous mixture add
dithiothreitol lul
labelling mix 2ul
[ -3 5 S]dATP 0. 5ul
Sequenase 2ul
Mix well and incubate at room temperature for 5-10 min.
Termination reaction
Add 2.5ul of the four different termination mixtures to four
separate Eppendorf tubes.(Each termination mixture consists of 4 x
80um dNTPs and 8uM of a single ddNTP, 50mM NaCl)
Add 3.5ul of the above labelling reaction to each termination mix
and incubate at 37°C for 5 min.
Terminate reactions with 4ul of stop solution (95% formamide, 20mM
EDTA, 0.05% Bromophenol Blue, 0.05% Xylene Cyanol FF).
Samples can be stored at -20 °C or heated at 80 °C prior to
electrophoresis.
Plasmids rescued from yeast and prepared for sequencing by the
method cited in the standard techniques section gave poor results.
Double stranded DNA was prepared in the following way. Rescued
plasmid was digested by Sail and EcoRI and the fragments separated
by gel electrophoresis. A 3kb fragment containing the BLG gene was
purified from the gel by electroelution using the Biotrap apparatus
then precipitated using 0.4 vols of 5M ammonium acetate and 2 vols
of isopropanol. Approximately Tug of this fragment in 15ul TE
(lOmM Tris-HCl pH 8, ImM EDTA) was denatured by adding 5ul of 1M
sodium hydroxide, ImM EDTA, and the mixture incubated at RT for 10
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min. Instead of neutralising the mixture and ethanol precipitating
the DNA, alkali was removed by spin dialysis. 20ul of sterile 200
micron glass beads in TE were added to a 500ul Eppendorf tube
followed by 150ul of Sepharose-6CBL equilibrated in TE. A hole was
punched at the bottom of the tube with a needle. The tube was
inserted into a 1.5ml Eppendorf tube and spun at lOOOrpm for 4 min
in an MSE benchtop centrifuge to remove excess fluid. The DNA
solution was added to the top of the column, spun as above and
collected in a fresh 1.5ml Eppendorf tube. The eluted DNA was
immediately sequenced using the Sequenase™ kit.
Sequencing gels were run on a BRL SO sequencing system then fixed,
dried down on 3MM paper and autoradiographed at RT using Hyperfilm
MP.
2.2.5 Growth of yeast
Two different kinds of media were used throughout these studies to
grow yeast: a rich non selective medium that allows rapid growth
and a synthetic selective medium which allows selection for cells
with an autotrophic marker supplied by a transformed plasmid.
Rich non selective medium (YPD)




Glucose was replaced with 2% (w/v) galactose to induce expression
from pBMl50 derived plasmids.
Synthetic selective medium called yeast omission medium (YOM)
Yeast nitrogen base 0.67% (w/v)
(without amino acids)
Glucose 2% (w/v)
























Leucine stock solution: 0.5% (w/v) leucine
Tryptophan stock solution: 0.2% (w/v) tryptophan
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Each stock solution was made up in distilled water, sterilised by
autoclaving and stored at 4°C. Tryptophan is light sensitve and
was covered with tin foil as an extra precaution. To produce the
desired selective medium, 1ml of each of the stock solutions was
added to YOM with a final volume of 100ml. Uracil and leucine were
omitted from the medium as required when selecting for uracil and
leucine autotrophs.
All of the above media were made up to the required volume with
distilled water and sterilised by autoclaving. Glucose, galactose
and glycerol were all autoclaved separately to avoid
caramelisation.
2.2.6 Transformation of yeast
Transformation was performed by the lithium acetate procedure.
Solutions:
LA 0.1M lithium acetate in TE
PEG 50% PEG 4000, filter sterilised
A small overnight starter culture was grown overnight in YPD at
30°C. This was then subcultured into 50ml of fresh YPD to give an
initial cell density of 1x10® /ml and grown at 30°C to a density of
approximately lxl07/ml ( 3xl06 cells/ml = 0.1 at 600nm). The cells
were harvested by spinning for 5 min at 2000rpm in an MSE benchtop
-49-
centrifuge, resuspended in 10ml TE, respun, and finally resuspended
in 5ml LA. The cells were shaken at 30°C for 1 hr and then
dispensed into 300ul aliquots in Eppendorf tubes. Up to lOug of
plasmid DNA was added in lOul to the tubes followed by 700ul of
PEG. The tubes were inverted gently to mix, placed in a 30°C water
bath for 1 hr then heatshocked at 42 °C for 5 min. At this stage
PEG could either be removed from the cells by centrifuging gently
and resuspending in TE, or 200ul of the cell/PEG solution could be
plated out directly onto selective plates (whichever method was
used, there did not seem to be any difference in transformation
efficiency). The plates were then incubated at 30°C and colonies
appeared within three to five days.
2.2.7 Plasmid rescue from yeast transformants
Colonies obtained from selective plates must be analysed to ensure
they result from transformation of the desired plasmid and are not
the result of contamination. The plasmid must be rescued from
yeast and transformed back into E.coli. Following isolation from
E.coli, the plasmid can be correctly identified by restriction
mapping.
A 5ml culture of cells was grown overnight at 30°C in selective
medium. The cells were harvested in a microcentrifuge and
resuspended in 800ul BME buffer (0.9M sorbitol, 50mM sodium
phosphate pH7.5, 2mM 2-mercaptoethanol). Lyticase (50u) were added
and the cells incubated at 30°C for 20 min, or until spheroplasts
had formed (add 5ul of 10% SDS to 5ul of cells, greater than 90%
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lysis is a good indication of spheroplast formation). Spheroplasts
were spun down at low speed in a microcentrifuge and resuspended in
lOOul of 1M sorbitol. Lysis buffer (800ul) was added (lOOmM Tris-
HCL, pH 9.7, 50mM EDTA, pH 8.5, 0.5% SDS) and the tubes were
incubated at 70°C for 20 min. Potassium acetate (200ul of 5M) was
added and the tubes were then incubated on ice for 45 min. The
tubes were spun at high speed in a microcentrifuge for 1 min and
the supernatant carefully removed, the pellet being discarded.
Following the addition of 550ul of isopropanol, the tubes were left
at room temperature for 5 min and then spun at high speed in a
microcentrifuge. The pellet was washed in 80% ethanol, dried and
resuspended in 20ul TE. lOul was then used to transform E.coli in
the usual manner.
2.2.8 Small scale preparation of crude yeast extracts
Cells were grown to late log phase and 1.5 ml were harvested in an
Eppendorf tube. The cells were resuspended in buffer (lOOmM Tris-
HC1, pH 7, 5% SDS, 20mM EDTA, 0.5% 2-mercaptoethanol) and glass
beads (0.45mm diameter) were added to .just below the meniscus. The
tube was then vortexed for two to three minutes and then boiled in
a water bath for 2 minutes. A small hole was then punched at the
bottom of the tube with a needle. The Eppendorf tube was inserted
into a 5ml Falcon tube and spun at 3000rpm for 5 min in an MSE
benchtop centrifuge. The suspension was removed from the Falcon
tube and respun in an Eppendorf tube to pellet cellular debris.
The crude cell extract was either analysed directly by SDS-PAGE or
stored at -20°C to limit proteolysis.
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2.2.9 Denaturing gel electrophoresis
Polyacrylamide gel electrophoresis was carried out according to the
method of Schagger and von Jagow [177]. Protein samples were
prepared by mixing with an equal volume of boiling mix (10% (v/v)
glycerol, 10% (v/v) stacking gel buffer, 2% (w/v) SDS, 5% (v/v) 2-
mercaptoethanol and 0.005% (w/v) Bromophenol Blue), boiling for 3
min and centrifuging for 10s at high speed in a microcentrifuge
prior to loading.
Native PAGE was performed using the same system except that no SDS
or 2-mercaptoethanol was used, the pH of all buffers was 8.6 and
the samples were not boiled before loading.
2.2.10 Western blotting
Crude yeast cell lysates were separated by SDS-PAGE and transferred
onto nitrocellulose by a semi dry procedure using an LKB transfer
system. A nitrocellulose membrane and six pieces of 3MM filter
paper were cut to the exact size of the gel. Two pieces of filter
paper were soaked in anode bufffer No.l, one piece in anode buffer
No.2 and the other three in cathode buffer. The gel was
equilibrated in cathode buffer for 5 min and the nitrocellulose
membrane was gently immersed in water to avoid the formation of air









anode buffer no. 1
Transfer was accomplished after 1 hr at a current determined by the
formula:
Area of gel x 0.8mA.
Anode buffer
No. 1
0.3M Tris, 20% methanol
0.1% SDS, pH 10.4
Anode buffer
No. 2
25mM Tris, 20% methanol
0.15 SDS, pH 10.4
Cathode buffer 25mM Tris, 20% methanol
40mM 6-amino-n-hexanoic acid
pH 9.4
The membrane was washed in Tris buffered saline (TBS) and blocked
for 1 hr in TBS + 0.5% Tween 20. Many of the standard blocking
agents, ie. Marvel, BSA and gelatin, contain trace amounts of BLG
and were unsuitable for immuno analysis. The membrane was
incubated with the primary antiserum, rabbit anti-bovine BLG
(kindly donated by Alan McAlpine), for 1 hr (or quite often
overnight at 4°C) and then washed five times in blocking buffer.
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The secondary antiserum ( peroxidase conjugated anti-rabbit IgG)
was added in blocking buffer at a dilution of 1/2000 and incubated
at RT for 2 hr. The membrane was washed five times in blocking
buffer and then developed.
Developer disolve 40mg 4-Chloro-l-napthol in 300ul
methanol, add to 100ml 50mM Tris-HCl pH 1.5
and lOOul 30% hydrogen peroxide, filter.
This developer was later superceded by the highly sensitive
Amersham ECL procedure. Using this procedure, the secondary
antiserum was incubated for only 20 min at an increased dilution of
1/5000 and the percentage of Tween 20 was increased to 1% in the
blocking solution.
2.2.11 H.p.l.c. and amino acid sequencing
Medium constituents plus the secreted BLG were concentrated using
Amicon ultrafiltration cells and separated by reverse phase
h.p.l.c. using an Applied Biosystems 130A Separation System. N-
terminal sequence analysis was performed by Edman degradation using
an Applied Biosystems 477A Protein Sequencer.
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2.2.12 C.d. spectroscopy
Spectra were carried out on a Jasco J600 spectropolarimeter using
0.1cm path length quartz cells. Samples were scanned from 260-
205nm at a temperature of 20°C. The c.d. analysis was performed by
Sharon Kelly at the Department of Biological and Molecular
Sciences, University of Stirling.
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3.0 Results
3.1 Subcloning the BLG gene
The full length coding sequence was obtained in the form of an
Sphl/Smal fragment inserted into plasmid pUC19 (fig. 3.0). The
insert comprised the complete coding sequence for the 162 amino
acid mature polypeptide, its own 18 amino acid leader sequence as
well as 83bp of upstream and 30bp of downstream noncoding DNA. The
DNA had to be manipulated to allow its insertion into a yeast
expression vector. In yeast, there do not seem to be the same
stringencies regarding the distance between promoter elements and
the begining of the coding sequence with the levels of expression
as those found in E.coli. However, it was still considered to be
advantageous to have the initiation of translation site as close to
the promoter as possible. As much upstream DNA as possible was
removed. This procedure had to be carried out in two stages
because any convenient flanking restriction sites also occurred
within the coding sequence. The plasmid was digested with PstI and
Smal to give a 343 bp Smal/PstI fragment encoding the C-terminal
portion and a 233 bp PstI fragment encoding the N-terminal portion
both of which were then purified. The Smal/PstI fragment was then
subcloned into plasmid pK18 followed by the PstI fragment (fig.
3.1). The correct copy number and orientation of the latter step
was verified by separate StuI and Aval digests. Plasmid pK18 is
similar in size and sequence to pUC19 but carries a different
antibiotic resistance gene. This alternative screening avoided
complications in restriction mapping arising from possible
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233bp 343bp








Sp = Sphl. P = Pstl. Sm = Smal
Figure 3.0 Diagram of pUC 1 9BLG
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Figure 3.1 Subcloning the BLG gene into plasmids pK18 and pUC1813.
1) Digest pUC19BLG with PstI and Smal.
2) Purify 233bp PstI fragment and 343bp PstI/Smal fragment.
3) Subclone Pstl/Smal fragment into pK18 followed by the PstI
fragment to form pK18BLG.
4) Digest pK18BLG with HindiII and Smal.
5) Blunt-end the HindiII end of the insert with Klenow fragment.




contamination by the parent plasmid. As well as removing 80bp of
upstream DNA, the complete coding sequence could now be moved about
as a single unit by means of a Hindlll/Smal digest. The single
stranded DNA overhang at the Hindi11 end of this fragment was
treated with the Klenow fragment of DNA polymerase to form a double
stranded "blunt end", from here on termed blunt-ending, and the
whole fragment was subcloned into the Smal site of plasmid pUC1813
(fig. 3.1). This latter subcloning step was purely a means of
providing BamHI restriction sites close to both ends of the insert
and as a result allowed convenient insertion into the expression
vector.
A low copy number plasmid with an inducible promoter was initially
used as the expression vector since the possibilty existed that BLG
expression would prove toxic to the cell. The BamHI fragment from
pUC1813BLG was inserted into plasmid pBM150 (fig. 3.2), an
autonomously replicating, centromere-containing yeast shuttle
vector that contains the URA3 gene for selection in yeast and the
ampicillin gene for selection in E.coli as well as an 800 base pair
region located between EcoRI and BamHI sites that contains the
promoters for the GAL1 and GAL10 genes [157]. Cloning the insert
into the BamHI site brought the expression of the BLG gene under





Figure 3.2 Insertion of the BLG gene into the expression vector
pBM150.
1) Digest pUC1813BLG with BamHI.
2) Subclone insert into BamHI site of pBM150 to form pBMBLG.
3) Verify correct insertion by EcoRI and Smal double digests.
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3.2 Expression of BLG
Plasmids pBM150 and pBMBLG were transformed into yeast strain
JRY188 and grown on YOM URA- plates. As already mentioned, these
vectors rely on an inducible GAL promoter to control expression,
the mechanism of which is briefly outlined below.
Galactose, when used as a carbon source, will be converted to
glucose-6-phosphate by enzymes of the Leloir pathway encoded by the
GAL genes. The GAL4 protein binds to sites upstream of each gene
and activates transcription. In the presence of glucose, the GAL80
protein binds to the GAL4 protein thus preventing transcription.
In the presence of galactose, an unidentified inducer molecule
prevents the GAL80 protein from inhibiting the function of the GAL4
protein. Glucose, when present, acts as a catabolite repressor and
any expression from the GAL genes is switched off, even when the
carbon source is present as a mixture of glucose and galactose.
The following small scale experiment was set up to look for BLG
expression. Different carbon sources were used to determine:
A) if continued growth in galactose was toxic
B) variations in BLG yield, if any, in cells
grown originally in non-repressive and
repressive carbon sources such as glycerol and
glucose, respectively.
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Exp.no. Starter culture 2nd culture
1 2% Galactose > o/n 2% Galactose > o/n
2 3% Glycerol > o/n 2% Galactose > o/n
3 2% Glucose > o/n wash 2% Galactose > o/n
4 2% Glucose > o/n 2% Glucose > o/n
Yeast transformed by pBM150 and pBMBLG were grown in 5ml of YP
medium containing the different carbon sources overnight. A small
aliquot was removed and grown overnight in 5ml of fresh medium
whereupon the cells were then harvested and lysed. Proteins that
had been secreted into the medium were precipitated with
trichloroacetic acid. Lysate samples were then analysed by SDS-
PAGE and stained with Coomassie Blue. Medium samples were also run
but the more sensitive silver staining procedure was used. In this
experiment cultures were grown in nonselective medium since, once
transformed, centromeric plasmids are supposed to be highly stable
The recombinant pBMBLG, if expressed, did not have any toxic effect
as cells gave the same gross appearance of cell density in
galactose as in glucose. SDS-PAGE of cell lysates failed to reveal
the presence of any extra bands from the recombinant over the non
recombinant strains. If BLG was being efficiently secreted, then
the amounts of intracellular protein would be minimal and so the
possibility existed that its presence was being masked by cellular
[158].
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proteins. However, the silver stained gel of the medium samples
failed to reveal any bands with a molecular mass comparable to that
of BLG.
The samples were once again run on SDS-polyacrylamide gels along
with 200ng of bovine BLG as a positive control. The presence of
BLG was determined by Western analysis using a polyclonal rabbit
antiserum raised against bovine BLG. Only the bovine control
produced a positive signal, albeit weakly. At this point, it was
realised that the acid stable BLG may not have been precipitated by
trichloroacetic acid. 500ug of bovine BLG was added to 5ml of
medium and treated with trichloroacetic acid. A sample was run on
an SDS-polyacrylamide gel, no BLG was detected by Coomassie
staining using this procedure. Another method would have to be
used to detect the protein.
Ammonium sulphate precipitation was carried out on YPD medium
containing BLG. Ammonium sulphate was added to 30% saturation and
stirred gently at 20°C. At first the solution became
characteristically cloudy but gradually cleared over a short period
of time. This also occurred at 60% and full saturation. Loss of
turbidity of the solution coincided with the appearance of a sticky
residue on the magnetic stirrer, the amount of which increased with
ammonium sulphate concentration. Any prospect of separating BLG
from such a mixture seemed poor. This did not seem a plausable
procedure for precipitating proteins secreted into the medium.
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Further silver staining analysis of medium samples concentrated by
ultrafiltration in Amicon systems and freeze drying also proved to
be unsuccessful. Concentrated medium is viscous and its complex
mixture produces unusual effects on gels such as highly erratic
band patterns and the lanes stain as a brown smear with some
protein bands staining a darker brown and others appearing as
unstained areas contrasting against the background.. By these
methods, it was impossible to determine whether there was any BLG
present in any of the media. Trichloroacetic acid precipitated
medium failed to produce these unusual effects, however, no BLG was
detected using this procedure. It was possible that the acid
treatment failed to precipitate the factors responsible for these
anomalies and as a result produced cleaner gels.
The following experiment was set up to compare cells grown in
selective YOM and non selective YPD media since:
A) it was possible that the "stable" plasmid was not being
maintained.
B) YOM medium contains far fewer constituents and would perhaps
provide cleaner gels.
Cells transformed with plasmids pBM150 and pBMBLG were grown in YOM
and YPD, harvested, lysed and analysed by SDS-PAGE. Once again no
BLG bands were detected by Coomassie staining. YOM medium from
both pBM150 and pBMBLG cultures was dialysed overnight in lxTBS,
freeze dried and finally analysed by SDS-PAGE. Two other medium
batches from pBM150 cultures were treated identically, however one
was spiked with BLG before dialysis and the other was spiked just
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before loading onto the gel. One other lane consisted of
concentrated undialysed YPD that also contained BLG. The gel was
first stained with Coomassie Blue and then silver stained (fig.
3.3). Only lanes spiked with BLG gave positive results. This gel
shows some of the problems associated with silver staining medium
extracts. The lanes stained well with Coomassie Blue however after
silver staining, the proteins stained both dark and light. The YPD
lane (lane 5) shows some of the swelling and erratic banding
discussed earlier. Although the BLG in this lane stains well with
Coomassie Blue it is very difficult to see it with the silver
stain. This gel also showed that BLG is not being degraded to any
great extent in the medium since the sample spiked before dialysis
appears as a large well defined band.
3.3 New expression vectors
It was still possible that BLG was being produced in very small
amounts as yet undetected. Two multicopy expression systems were
used in the hope of amplifying the amount of protein.
Plasmid pVT102u is a multicopy shuttle vector that, along with the
various selection genes, contains a multiple cloning site located
between the promoter and downstream control sequences of the yeast
ADH1 gene [159]. The BamHI/Smal BLG fragment from pUC1813BLG was
inserted into the BamHI/PvuII site of the vector to form pVTBBLG
(fig. 3.4).
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1 2 3 4 5
Figure 3.3 Silver stained SDS-polyacrylamide gel of concentrated
medium supernatants.
1. YOM + pBMBLG
2. YOM + pBM150
3. YQM spiked with BIjG before dialysis
4. YOM spiked with BLG just prior to SDS-PAGE




Figure 3.4 Insertion of the BLG gene into the expression vector
pVT102u.
1) Digest pUC1813BLG with BamHI and Smal.
2) Subclone insert into BamHI/PvuII site in pVT102u to form pVTBBLG
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The second system was a hybrid of pBMBLG and the vector above. The
promoter and down stream sequences from pVT102u were removed by
SphI digestion and discarded. The remaining plasmid DNA was blunt-
ended with T4 DNA polymerase. The EcoRI/Smal fragment containing
the GAL1/GAL10 promoter region and the BLG coding sequence from
pBMBLG was purified and blunt-ended with Klenow fragment from DNA
polymerase and inserted into the vector to produce a galactose
inducible multi copy expression plasmid called pVTSBLG (fig. 3.5).
In the above two systems, the correct copy number and orientation
of inserts was determined by restriction analysis.
PVTSBLG was transformed into yeast strain JRY188, and pVTBBLG was
transformed into strain DBY747. Both were plated out on YOM URA-
plates and transformants were analysed by plasmid rescue and
restriction mapping.
Constitutively expressed plasmids pVT102u and pVTBBLG were grown
overnight in 1ml of YOMglu. Galactose inducible plasmids pBM150,
pBMBLG and pVTSBLG were grown in YOMgal. The cells were harvested,
lysed and analysed by SDS-PAGE; the medium was dialysed against
lxTBS at pH7, freeze dried and half of each sample was analysed in
by SDS-PAGE. Once again no extra bands corresponding to BLG were
visible in any recombinant lanes.
Cellular extracts and the rest of the medium samples were blotted
onto nitrocellulose along with BLG controls at differing
concentrations using the Bio-Rad dot blot apparatus. Rabbit anti-
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Figure 3.5 Generating a multicopy inducible expression vector,
pVTSBLG.
1) Digest pVT102u with SphI.
2) Discard the small SphI fragment containing the control elements
and blunt-end the remaining plasmid DNA with T4 DNA polymerase.
3) Digest pBMBLG with EcoRI and Smal.
4) Blunt-end the EcoRI end of the purified fragment, containing the
GAL1 promoter and the BLG gene, with Klenow fragment.




BLG antiserum was used to detect the presence of BLG but results
were negative apart from the controls. However, controls at
concentrations of less than lOOng failed to develop which may
suggest a lack of sensitivity of the antisera or some factor
concerning development.
At this stage two possibilities existed:
A) the expression was so small as to have escaped detection
or B) the cells were not producing BLG.
Increasing the culture size from 5ml to, for example, 1 litre,
might reveal the presence of the protein. However, apart from the
problems associated with scaling up the procedures, especially
concentrating the medium from so many samples, it was felt that if
the yield was so low using these expression systems, unmanageable
volumes of cultures would have to be grown to provide enough
protein for adequate analysis. Another method would have to be
used to optimise expression of BLG.
Up until now there was no evidence of BLG being synthesised let
alone secreted. Although this problem might have been solved by
scaling up the experiments, the possibility existed that, for one
of a variety of reasons (see later), the mature protein was not
being synthesised. However, some light was shed on the matter by
checking the preliminary subcloning steps with sequence constructs
in the VAX mini-computer. In plasmid pK18BLG (fig. 3.1) an SphI
site existed between the Hindi 11 and PstI sites, a fact not taken
into consideration in the design strategy. This restriction site
contained an ATG codon that was in frame with respect to the BLG
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coding sequence. Initiation of translation would most likely occur
at this upstream ATG resulting in the addition of four extra amino
acids, Met-Pro-Ala-Ala, onto the front of the leader sequence. It
was unclear how the addition of these amino acids onto the leader
sequence would affect the final destiny of the protein as it had
not even been ascertained whether yeast would direct secretion of
BLG using its own leader sequence. In addition to this, the
possibility also existed that, due to some cloning artefact, there
was a mutation within the coding sequence. Assuming that the
native leader would prove functional, it was decided that the short
stretch of DNA encoding the extra amino acids would be removed and
the complete DNA coding sequence checked for mutations.
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3.4A Lack of expression - Possible causes
As already mentioned, no BLG protein was detected using the GAL1
and ADH1 promoters. There are several stages where expression and
secretion of BLG may have failed.
If the promoters were not functional, then transcription of the
gene would not have been initiated. To test this, the gene
encoding some other protein commonly used in yeast expression
studies, eg. B-galactosidase, could have been inserted next to the
promoters. Successful expression could then be detected by simple
enzyme assay. However, both these promoters successfully directed
expression of Drosophila ADH in the same laboratory [160], which
probably rules out failure at this particular stage.
The addition of the extra four amino acids has already been
implicated in the breakdown of the pathway. This could be verified
by excising the DNA encoding these amino acids and reinserting the
genes into the expression plasmids to look for expression. A
successful result to this experiment would still raise questions as
to the precise problem caused by these amino acids. Problems may
have arisen at the levels of transcription, translation and/or
protein stability. The presence of specific transcripts could be
determined by Northern analysis. Abundant levels of mRNA not
resulting in detectable protein may point to problems during
translation or protein stability whereas low yields of BLG mRNA may
point to problems of transcription or mRNA stability. mRNA half-
life is determined by the rate of transcription, mRNA stability and
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the amount of mRNA removed as a result of translation. The BLG
mRNA half-life can be determined by adding transcriptional
inhibitors such as phenanthroline to an exponentai1ly growing
culture. The abundance of BLG mRNA isolated at various time points
can be determined by dot blot or Northern analysis using radio
labelled BLG cDNA as a probe. If the mRNA half-life is extended in
the presence of translational inhibitors such as cyclohexamide this
may suggest that at least some of the mRNA turnover results from
translation. If the half-life in the presence of cyclohexamide
remains the same this may suggest that the problem may be one of
transcript stability, which may be especially true for the GAL1
promoter directed transcripts which are probably not
polyadenylated. However, care must be taken in making absolute
conclusions since there is a complex interplay between
translational efficiency and mRNA half-life that is poorly
understood. As a result, possible aberrations arising from the use
of these metabolic inhibitors must be taken into account.
Problems resulting from translation may be detected in polysome
gradients. Fractionation of the gradient followed by dot blot
analysis may show a lack of ribosome binding pointing to problems
arising from initiation or premature termination of translation.
Gradual degradation of the BLG protein could be followed in the
presence of cyclohexamide. Detection of the desired protein would
be accomplished by Western analysis using an antiserum specific for
BLG. Loss of intracellular signal not paralleled by a concomitant
increase in secreted BLG levels would suggest the occurence of
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protein degaradation. The formation of insoluble aggregates cannot
be ruled out. Treatment of the heavy membrane fraction with urea
and 2-mercaptoethanol may solublise aggregated BLG.
Before carrying out these control experiments to resolve the above
questions, it was decided to proceeed with the expression studies
using one of the most powerfull yeast promoters inserted next to a
BLG gene without the extra four amino acids in a final attempt to
gain functional expression.
3.4B Sequencing the BLG gene
The Sphl/Smal fragment from pK18BLG was purified and blunt-ended
using T4 DNA polymerase. This insert was then subcloned into
pUC1813 to provide BamHI restriction sites. This plasmid was
called pUC1813TBLG. From there, the BamHI fragment was removed and
inserted into bacteriophage M13mpl8 for sequencing. Since inserts
were obtained in both orientations, the full insert could be
sequenced using the universal primer. Sequence results showed
three changes from the expected sequence. However, none of these
changes would affect the transcription or translation of BLG.
A) There was a G-> T substitution in the eleventh codon of the
mature polypeptide. The full coding sequence from plasmid pUC19BLG
had originally been constructed in another laboratory from genomic
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DNA and cDNA. This mutation was present as a design error in the
oligonucleotide used to link the two fragments. Fortunately, this
was a silent mutation and so failed to change the amino acid
sequence.
B) There were two artefactual mutations outside the coding sequence
(fig. 3.6).
The cloning procedure, involving the excision of the upstream ATG,
resulted in the loss of two C residues from the noncoding upstream
end and two G residues from the noncoding downstream end. The loss
of these residues cannot be explained by a lack of detection
arising from stacking artefacts on sequencing gels as many similar
strings of residues were always distinguishable. It is impossible
to determine whether the two C residues were lost from the insert
or the vector pUC1813. However, since the two G residues were lost
from the vector, it is likely that there was limited degradation of
the Smal digested vector resulting in the loss of these residues.
The cause must remain unknown. The evidence from the sequence data
was further supported when the plasmid, once tested, failed to be
cleaved by Smal.
3.5 Expression using plasmid pMA91
The DNA sequence had now been checked and the short stretch of DNA
coding for the extra amino acids removed. The question now arose
as to whether the extra amino acids had caused the protein to be
degraded, or whether any lack of expression was a result of the
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Hindi 11 Sphl Smal
AAGCTTGCATGCCTGCA GCCATG- CCC GGGTAC
TTCGAACGTACGGACGT CGGTAC GGG CCCATG




2) blunt-ending with T4 DNA polymerase
->
\/







CCTAGGGG GGACGTCGGT AC GGG CCCCTAGC
pUC18 1 3 INSERT pUC 1813 >
* missing residues determined by DNA sequencing
Figure 3.6 Mutations generated outwith the coding sequence during
removal of the upstream ATG.
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expression systems being in some way unsuitable. Other studies
within the group, involving the expression of Drosophila ADH using
the same vectors and the same yeast strains failed to detect
expression at the protein level [160]. The protein was finally
isolated when a different yeast strain was used to conduct the
experiments.
It was decided to use a different yeast strain together with a
different expression plasmid which contained one of the strongest
known yeast promoters.
Plasmid pMA91 is a multicopy yeast shuttle vector that contains the
LEU2 gene for selection in yeast and the ampicillin gene for
selection in E.coli. The plasmid contains the PGR promoter as well
as the PGK downstream control sequences and has been used
successfully for the high level expression of calf prochymosin
[161]. The BamHI fragment from pUC1813TBLG was inserted into the
Bglll site next to the promoter, destroying the cloning site in the
process, to form pMABLG (fig. 3.7). Recombinants were mapped with
Hindlll/PvuII and EcoRI/PvuII double digests to ensure single copy
insertion in the correct orientation. Plasmids pMA91 and pMABLG
were both transformed into yeast strain AH22 and plated out on YOM
LEU- plates. Transformants were analysed by plasmid rescue and
restriction mapping.
Cells transformed with plasmids pMA91 and pMABLG were grown
overnight in 10ml of YOM LEU- medium. This starter culture was
then added to 100ml of the same medium and grown for a further 24
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Figure 3.7 Insertion of the BLG gene into the expression vector
pMA91.
1) Digest pUC1813TBLG with BamHI.
2) Subclone the insert into the Bglll site of pMA91 to form pMABLG.
For sequencing and site-directed mutagenesis, the BamHI fragment
from pUC1813TBLG was inserted into bacteriophage M13. Mutant genes
were subsequently subcloned into pMA91.
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hours. The cells were harvested, and lysates were analysed by SDS-
PAGE and stained with Coomassie Blue (fig. 3.8A). No BLG bands
were detected in the cell extracts, although, the possibility
existed that its presence was being masked by cellular protein
bands.
The medium was concentrated from 100ml to 8ml using an Amicon
ultrafiltration cell and then dialysed against 20mM sodium
phosphate at pH6.5 overnight. After dialysis, the medium was
concentrated in an Amicon microconcentrator to 300ul. Concentrated
medium samples of 2.5ul from recombinant and non recombinant cells
were analysed by SDS-PAGE and stained with Coomassie Blue (fig.
3.8B). There were striking differences between the two samples.
Bands the size of BLG were present in the recombinant lane that
were totally absent in the non recombinant lane. Both lanes
exhibited identical band profiles which represented other proteins
common to both medium samples. It was more than likely that these
bands in the recombinant lane resulted from the presence of BLG.
30ul of this concentrated sample was analysed by reverse phase
h.p.l.c. and produced the elution profile shown in fig. 3.9. The
major peak was collected for sequencing. The first 10 amino acids
were determined (fig. 3.10) and gave the following sequence:
Ile-Ile-Val-Thr-Gln-Thr-Met-Lys-Gly-Leu
The amino acid sequencing was kindly performed by Linda Kerr.
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Figure 3.8B SDS-PAGE of concentrated medium supernatants. Amount




buffer A: 0.1 % TFA in water
buffer B: 0.08S TFA in 70% ACN
TFA = trifluoroacetic acid
ACN = acetonitrile
Figure 3.9 Reverse phase h.p.l.c. profile of concentrated medium.
-78-
cycle 1 2 3 4 5 6 7 8 9 10
Ala 16.7 4.6 3.7 8.4 0.5 -1.4 -0.3 0.4 1.5 0.2
Arg 1.8 0.9 3.0 -1.0 -0.2 -0.1 -0.4 0.4 0.2 0.1
Asn 0.5 -0.3 0.5 -0.4 -0.7 -0.4 -0.1 0.6 0.4 -0.2
Asp 16.1 -0.6 1.0 0.2 -1.0 0.6 6.3 6.8 4.7 -0.1
Cys -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -1.0 -0.1
Glu 1.9 -1.6 -1.5 0.7 64.9 1.5 3.1 0.2 1.6 -1.3
Gin -0.4 -0.1 -0.2 5.7 281.3 1.9 1.5 -1.9 2.9 -2.7
Gly 6.2 3.5 -0.4 -2.1 -2.0 4.6 -1.6 0.7 239.8 0.0
His 0.3 0.0 -0.1 -0.1 0.2 -0.2 -0.4 -0.1 0.5 0.0
lie 460.3 410.2 0.0 0.7 6.6 0.0 -1.3 -0.2 0.1 0.7
Leu 6.4 3.2 1.0 -0.2 -0.9 -0.6 1.7 0.0 0.6 263.8
Lys -0.4 -0.4 0.3 -0.1 1.8 -0.4 -0.9 290.4 2.7 0.8
Met 0.4 -0.3 0.4 0.3 -0.3 -1.0 306.0 0.6 1.5 0.5
Phe 1.8 0.5 0.2 0.0 -0.4 -1.0 -0.7 0.6 0.7 1.6
Pro 0.8 -1.2 -0.6 4.0 6.0 1.2 5.1 4.3 0.9 1.3
Ser 2.6 0.4 0.2 -0.9 1.1 -0.4 0.5 1.5 0.4 -0.3
Thr 0.7 0.0 -1.4 265.0 0.0 212.2 2.7 1.6 0.2 -1.2
Trp 4.7 -0.3 2.9 -0.3 0.8 0.8 -1.2 3.3 0.0 0.1
Tyr -0.5 1.4 0.5 0.6 -0.6 -0.2 0.3 1.4 0.5 -0.6
Val 0.5 3.7 369.2 0.2 -0.7 -0.8 0.3 0.5 0.2 4.8
Figure 3.10 N-terminal amino acid sequence analysis. Lag
corrected tabulation, in pmols, of the amino acids released
by 10 cycles of Edman degradation.
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This agrees with the predicted sequence of the mature ovine BLG
protein obtained from the translation of the DNA sequence as well
as that of the amino acid sequence for the protein [19].
These results show that recombinant cells synthesise ovine BLG
which is successfully secreted into the surrounding growth medium.
Comparisons between the band intensities on polyacrylamide gels
with a known amount of bovine BLG standard showed an approximate
yield of 6-8mg per litre of culture (fig. 3.8B). As well as
confirming the identity of the protein, the amino acid sequence has
shown that the protein has been correctly processed, with regard to
its cleavage from the leader sequence, and is present in its mature
form.
BLG on the denaturing gel was present as two bands of equal
intensity. This cannot be readily explained. The BLG control is a
mixture of bovine variants A and B and it is possible, though
unlikely, that the slight difference in amino acid composition
could lead to variations in the mobility of the two proteins in
denaturing gels. However, this argument cannot be used for the
ovine protein since it is synthesised from a single gene. This
artefact is most likely caused by the incomplete unfolding of
protein secondary structure perhaps as a result of insufficient
reducing agent.
Identical amounts of bovine BLG were boiled for five and ten
minutes in sample buffer containing fresh 2-mercaptoethanol.
Another sample was boiled for five minutes in sample buffer lacking
80-
2-mercaptoethanol. The samples were then run on an SDS-
polyacrylamide gel and stained with Coomassie Blue (fig. 3.11).
The proteins boiled in 2-mercaptoethanol were still present as two
bands, even after ten minutes, but the higher molecular mass band
was now more prominant. The protein boiled in the absence of 2-
mercaptoethanol was present as a single band but migrated further,
as expected, due to the presence of limited secondary structure
provided by the non reduced disulphide bridges. There has been no
report of this anomaly regarding BLG in the literature. This is
not surprising since most of the electrophoretic analysis has
involved the use of non denaturing conditions. Studies involving
SDS-PAGE [162] have only revealed single bands. However, since the
amount of BLG loaded onto these gels seems quite large, judged by
the heavy band intensities, it is possible this doublet may be
masked by overloading. Many subsequent gels have shown slight
variations in BLG band profile but the one discussed here seems to
be most prevalent. It is likely that the slower band is the fully
denatured protein and the faster band has either lost some amino
acids or has limited secondary structure. If this is so, it cannot
be readily explained how identical conditions can produce two
distinct populations of proteins.
3.6 Large scale preparation of BLG
Simple purification procedures of BLG from bovine milk have relied
on properties of the native protein and have been well documented
(see introduction). However, there were no guarantees that yeast
would synthesise the protein in its structurally native form,
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1 2 3
Figure 3.11 SDS-PAGE of bovine BLG
1. BLG boiled for 5 min + 2-mercaptoethanol.
2. BLG boiled for 10 min + 2-mercaptoethanol.
3. BLG boiled for 5 min - 2-mercaptoethanol.
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enabling the use of such procedures. The possibility also existed
that constituents in the medium may affect the behaviour of the
protein in solution. A new protocol was devised in the hope of
obtaining enough pure protein to characterise its solution
properties.
A 2.5 litre culture was grown to stationary phase in unbuffered YOM
LEU- medium. The cells were removed by centrifugation and the
medium was concentrated from 2.5 litre to 12ml at 4°C using Amicon
ultrafiltration cells with YM10 filters which had a relative
molecular mass (Mr ) cut off of 10,000. During concentration, a
precipitate gradually formed which was removed by centrifugation.
It was unclear at this stage whether the precipitate was already
present but too dilute to see in unconcentrated medium or whether
it was a result of some concentration factor. The supernatant was
subsequently dialysed overnight in 50mM sodium phosphate, pH6.2, at
4°C. The approximate protein concentration in the supernatant was
determined by its relation, mg of protein/ ml = 1.11 x absorbance
at 280nm [163]. There was approximately 24mg of protein in 12ml of
supernatant. Gel electrophoresis showed BLG to be the most
abundant protein present. It is interesting to note here that the
pH of the medium at stationary phase was 2.94. The electrophoresis
step mentioned above showed that BLG is soluble at this pH which
may suggest the protein exists in its native form. However, SDS-
PAGE of the precipitate resuspended in buffer showed that BLG is a
major component. This aspect will be discussed later. The
supernatant was then fractionated by ion exchange chromatography.
The sample was loaded onto a 2cm x 5cm DEAE Sephadex A50 column
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which was then washed with several column volumes of 20mM sodium
phosphate buffer at pH 6.2. Protein was eluted from the column in
a 0 to 0. 1M sodium chloride gradient in 20mM sodium phosphate
buffer at pH6.2. This was followed by a single step wash in 1M
sodium chloride in the same buffer. The elution profile and the
SDS-polyacrylamide gel of the gradient eluent fractions are shown
in figure 3.12.
The elution profile showed some material eluting in the void volume
during loading of the sample and a broad peak eluting from the
gradient covering fractions 26 to 60 which may be an accumulation
of several peaks. Gel electrophoresis showed that BLG was eluted
throughout the range of the broad peak with only minor
contamination of higher molecular mass bands. No BLG was detected
in either the early peak, which represented material that failed to
bind to the column, or in the peaks eluting in the 1M sodium
chloride step. The bed height of the column decreased
significantly during elution. As the sample was eluted by
increasing ionic strength, it was then subjected to gel filtration
effects of the shrinking column. This may account for BLG eluting
as a broad peak, however, it is also possible the gradient was too
broad. A different ion exchange matrix less susceptible to
shrinkage would be utilised in future.
Ion exchange chromotography had removed many of the contaminants
present in the sample and the ones remaining were thought large
enough to be separated by gel filtration.
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Figure 3.12 Elution of BLG from Sephadex A50.
Bed size: 2 x 5cm.
Eluent: 0 to O.IM sodium chloride gradient in 20mM Sodium
chloride buffer, pH 6.2, followed by a 1M salt wash.
[NaCl]
(M)
1 23456 7 8 9 10 a 11
SDS-PAGE of fractions collected from the broad peak.
Position of the arrows indicate higher molecular mass bands.
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The fractions containing BLG were pooled and concentrated to a
final volume of 5ml. The sample was then dialysed in several
changes of distilled water, freeze dried and resuspended in 850ul
of 50mM sodium phosphate buffer at pH6.2. Next it was loaded onto
a 1.6cm x 94cm Sephacryl HS 200 column and eluted in the same
buffer. Eluent fractions were analysed by SDS-PAGE which showed
that BLG, eluted from the column, appeared to be pure (fig. 3.13A).
The fractions were then pooled and concentrated. This supernatant
contained dextran blue which had previously been used to estimate
the void volume of the column. The supernatant was dialysed in
distilled water then freeze dried. The precipitate was resuspended
in lOOul of water and 2ul of this sample was analysed by SDS-PAGE
(fig. 3.13B).
This purification procedure showed that BLG had eluted at the void
volume suggesting the protein had formed high molecular mass
aggregates which dissociated under the denaturing conditions during
electrophoresis. It is possible that freeze drying the protein
before chromatography had favoured the formation of such complexes.
Freeze drying may not be a suitable procedure for concentrating BLG
at this stage. This hypothesis is supported by comparing figures
3.13A and 3.13B. There are many bands present in figure 3.13B not
present in figure 3.13A. These bands are possibly aggregates of
BLG but some may represent contaminants too dilute to be seen in
unconcentrated supernatant. However, the eluent from the column
was cloudy which might have been a result of microbial
contamination. The yield of protein, recovered from the column,
was lower than expected. The ionic strength of the sodium
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Figure 3.13A SDS-PAGE of BLG eluted from the Sephacryl HS200
column.
*
Figure 3.13B SDS-PAGE of freeze dried eluent from the Sephacryl
HS200 column.
1. Freeze dried sample 2. BLG
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phosphate elution buffer may not have been sufficiently strong to
inhibit the formation of weak ionic interactions between the
protein and the column matrix. That such interactions occurred was
shown when the column was washed in 1M sodium chloride. As the
buffer washed through the column, the leading front of the buffer
gradually acquired dextran blue which finally eluted as a single
band.
Many conditions used in this first attempt at large scale protein
purification would be altered in subsequent procedures. However,
it was felt more important to concentrate on making the protein
mutants, discussed in the introduction, and delay refinement of the
purification procedures until this had been achieved.
3.7 Site-directed mutagenesis of BLG
Mutant BLG genes were generated to answer some questions regarding
the roles played by certain amino acids in determining the
structure of BLG. Two methods were used to compare efficiency and
ease of creating mutants: one was based on the Eckstein procedure
outlined in the Amersham manual, and the other was the Kunkel
procedure [164]. Two different orientations of insert in M13 were
used as templates, as in the previous sequencing steps, so that
each mutant could be verified by sequencing using the universal
primer. The following mutations were made.





ol i go 119
115 119 125
QSLASQCL VRT





TCG GAC CGG AGG CAG TGC CTG
115 119 121 125
QSLAC QCLVRT
5' CAA AGC CTG GCC TGC CAG TGC CTG GTC AGG ACC 3'




mutant 5' CAA AGC CTG GCC TGC CAG TCC CTG GTC AGG ACC 3'
sequence







L L S I D S A
5' CAG CAG GGA GAT GTC GCT GGC C 3'
\i/
**
3' GTC GTC CCT CAG CAG CGA CCG G 5'
26 29 32
L L S D D S A
5' CAG CAG GGA GTC GTC GCT GGC C 3'
Figure 3.14B Oligonucleotide used to create mutant 29.
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The creation of these mutants would hopefully settle the
controversy regarding the position of one of the disulphide bridges
discussed in the introduction.
Isoleucine 29 was changed to an aspartate (fig. 3.14B).
X-ray crystallography analysis of the BLG dimer indicated that this
isoleucine on each monomer formed hydrophobic interactions at the
dimer interface. The negative charge on the side chain of aspartate
might provide enough repulsion to prevent dimerisation. The
monomers would then prove suitable for NMR studies.
Lysine 70 was changed to an asparagine (fig. 3.14C).
This last mutant would be the first in a series to alter the
residues involved in the hydrophobic pocket. The most up to date
model has shown that lysine 70 is located at the entrance to the
pocket and may be involved in binding the hydroxyl group in the
isoprene tail of retinol. Substituting lysine with asparagine may
affect binding of retinol to BLG and thus confirm the role of the
hydrophobic pocket as the binding site.
Two plaques from each mutant transformation were sequenced. Six
out of eight plaques proved to be mutant. One made by the Eckstein
method was a wild type and one from the Kunkel method generated
unreadable sequence as a result of a sequencing artefact. Both
mutagenesis methods had a comparable efficiency and both were






A I I K K Q
5' C TGC AAT AAT CTT CTT CTG AG 31
3" G ACG TTA TTA CAA GAA GAC TC 5'
67 70 72
M/ A I I N K Q
mutant 5' C TGC AAT AAT GTT CTT CTG AG 3'
sequence
Figure 3.14C Oligonucleotide used to create mutant 70
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Once the mutants had been made, the specific regions were checked
by sequencing. The mutations generated are shown in figure 3.15.
The inserts were removed by BamHI digestion and cloned into the
expression vector pMA91. Recombinant plasmids were then mapped to
ensure correct insertion. All mutant vectors were transformed into
yeast strain AH22 and plated out on YOM LEU- plates. Transformants
were then analysed by plasmid rescue and restriction mapping.
There appears to be some controversy whether yeast transformation
is mutagenic. Having already sequenced and verified the presence
of the desired mutations, it was decided to sequence the complete
gene of each mutant as well as that of the wild type. In order to
save having to subclone these genes back into bacteriophage Ml3
from the expression vector, a double stranded protocol was
attempted. This method proved unsuitable in that runs of the same
bane were unreadable on sequencing gels. The inserts would have to
be subcloned into Ml 3. There was a problem in that the insert
could not be excised using BamHI since the restriction site had
been lost on cloning into the Bglll site of the expression vector.
Plasmid pMABLG was mapped with a variety of restriction enzymes in
order to find a site that would excise the gene in a small enough
fragment to allow the use of the M13 universal primer to sequence
the beginning of the BLG gene. No convenient sites were found. A
large fragment would have to be subcloned in a particular
orientation and a new oligonucleotide designed to sequence the
beginning of the gene. When annealed, the 3' end of this




Figure 3.15 DNA sequence analysis of mutant BLG genes.
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5' GGAGTAATTATCTACTTT 3"
Figure 3.16 Oligo 050G. This oligonucleotide was used as a







Figure 3.17 DNA sequence comparison of oligonucleotide 70 and
bacteriophage M 13 .
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upstream from the ATG codon of the BLG gene. Mutant
oligonucleotides 29 and 70 could also be used as primers to allow
sequencing of the rest of the gene.
The 3kb Sall/EcoRI fragments, from all pMABLG vectors, containing
the the wild type and all mutant BLG genes were cloned into Ml3.
Clear plaques were analysed by the T tracking procedure to verify
the presence of inserts. Oligonucleotide 70 was used as the
primer and the M13 recombinant, MPBLG, as a positive control. All
of the plaques and the control produced aberrant band profiles but
since the bands had strong intensities, some sequencing artefact
was suspected. However, when the plaques were sequenced using
oligonucleotide 70 as a primer, it was discovered that all the
plaques were non recombinants. It was found that oligonucleotide
70 had a strong recognition for a particular stretch of Ml 3 DNA
(fig. 3.17), which accounted for the aberrant T tracking profiles.
The control profile was complicated by the primer initiating T
tracking at two different sites. In order to avoid having to
design a new oligonucleotide to replace oligonucleotide 70, another
attempt was made at sequencing the genes without subcloning into
M13.
All recombinant pMA91 derived plasmids were digested by Sail and
EcoRI and the fragments separated by gel electrophoresis. Each 3kb
Sall/EcoRI fragment containing a different BLG variant was
purified by electroelution using the Biotrap and a different double
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stranded sequencing protocol, described in the Materials and Method
section, was followed. The three oligonucleotides, mentioned
above, were used as primers.
The BLG gene was sequenced from a linear fragment, rather than from
the complete expression vector for two reasons. Firstly, to
minimise the risk of the oligonucleotides annealing to locations
other than those desired, as much of the vector had not been
sequenced. Secondly, purifying the fragment with the Biotrap was
an excellent way of removing any contaminants, thus avoiding many
sequencing artefacts.
The wild type and all four mutant genes were successfully sequenced
using this method. No mutations, other than those synthesised,
were detected in any of the genes. It could now be assumed that
any alterations in protein behaviour resulted from mutations
deliberately generated.
Now that all of the mutations had been made and the full coding
sequence of each verified, it was necessary to determine whether
the mutants would be successfully secreted.
3.8 Expresson of BLG mutants.
Small 10ml cultures of yeast transformed by all mutant and control
recombinant and non-recombinant plasmids were grown in YOM LEU-
medium. The cells were harvested, lysed and extracts analysed by
SDS-PAGE. Medium from each culture was concentrated to 1ml by
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ultrafiltration and then freeze dried. Precipitates were
resuspended in 50ul of distilled water from which lOul samples were
analysed by SDS-PAGE (fig. 3.18). Both gels were stained with
Coomassie Blue.
No BLG was detected in any of the cellular extracts. The gel of
the medium samples showed that mutants 29, 70 and 121 were all
secreted into the medium but there was no band corresponding to
mutant 119. The search for intracellular BLG was repeated using
Western analysis (fig. 3.19). All lanes, including the negative
control, appeared to have the same doublet of bands associated with
2-mercaptoethanol-treated BLG. The Coommassie blue stained
cellular extracts in figure 3.8A showed two yeast bands almost
identical in size to BLG. The antiserum in the present experiment
was affinity purified, however, results showed that it recognised
many yeast cellular epitopes. Since the cellular yeast bands in
question stained strongly with Cooiranassie blue, it was not
unreasonable to expect such an antiserum to generate an equally
strong signal. Even though all lanes from the Western gel
contained a large amount of background noise, a band comparable in
size to the larger band of the BLG control was clearly visible in
the mutant 119 lane that was not present in any other. It seemed
likely that this band represented unsecreted mutant 119 BLG.
Conclusive evidence will only be obtained when a specific
antiserum is developed or when the protein can be purified in
sufficient quantities to sequence. There was no information
regarding its location within the cell.
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All mutant proteins that were secreted into the medium were not
detected from intracellular crude extracts. The purported
detection of intracellular mutant 119 protein by Western analysis
suggests that the secretion pathway for this particular mutant has
in some been inhibited post translationally and may result from
problems of protein instability. The amount of mutant 119 detected
within the cell did not match the secreted amounts of the other
mutants i.e. there was no equivilent intracellular accumulation of
mutant 119 protein. This may suggest that the protein is being
degraded. Crude cell extracts can be prepared from exponentially
growing cultures at various time points following addition of
translational inhibitors such as cyclohexamide. Using an anti-BLG
antiserum to detect mutant 119, loss of signal will occur if the
protein is being degraded. If so, the site of degradation may be
ascertained by the fractionation of whole cell lysates on Percoll
gradients followed by SDS-PAGE and Western analysis. However, loss
of detectable intracellular BLG may result from aggregation of the
protein. Aggregates, formed by intra and inter chain disulphide
bridges, would have been removed during the centrifugation step
when preparing the soluble cell lysate fraction. Since BLG
aggregates are difficult to solubilise with SDS and 2-
mercaptoethanol alone, long incubations in 8M urea and reducing
agents would be required. Any BLG solubilised by such a procedure
could then be detected by Western analysis.
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Figure 3.18 SDS-PAGE of native and mutant ovine BLGs secreted into
the growth medium. Medium from each yeast culture (denoted above)
was concentrated 20 fold and lOul from each concentrate along with
8ug of a bovine BLG standard was separated on a 9% polyacrylamide
gel. The gel was then stained with Coomassie Blue.
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Figure 3.19 Western blot of cellular extracts. Samples (5ul) of
crude cell extracts prepared from cultures carrying the plasmids
denoted above, were separated on a 9% polyacrylamide gel.
Following electroblotting onto nitrocellulose, the membrane was
probed with a rabbit antiserum raised against bovine BLG. Bound
antibodies were detected by a futher incubation with peroxidase
conjugated anti-rabbit IgG followed by development using the
Amersham ECL procedure.
► = position of mutant 119 BLG
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Now that the expression of all mutants and secretion of three had
been verified, it was necessary to concentrate on refining a large
scale protein purification procedure which would hopefully be valid
for the native protein and, ideally, all subsequent secreted
mutants.
3.9 Small scale purification of BLG
Small test experiments were set up in an attempt to enhance the
amount of BLG secreted and optimise protein purification
procedures.
3.9.1 Secretion of BLG in different media
Cells containing the native ovine gene were grown in 5ml of YOM
LEU- medium. Aliquots were then subcultured into three flasks
containing 50ml of YOM LEU- medium and 50ml of YPD medium, at a
density of lxlO6 cells per ml. The cultures were aerated at 30°C
for 16, 24 and 48 hours. After the appropriate time had elapsed,
the cells from a pair of cultures grown in YPD and YOM were
harvested and the medium concentrated with an Amicon
ultrafiltration cell. This medium was further concentrated to
400ul using Millipore Ultrafree-MC units which consisted of a small
cup with a filter sealed at the bottom. This filter had a Mr cut
off of 10,000. The cup was then inserted into a 1.5ml Eppendorf
tube and spun at low speed in a microfuge. Medium passed through
the filter and was collected in the Eppendorf tube leaving a small
volume, containing molecules larger than lOkDa, in the cup. The
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cup could then be refilled with more medium and the process
repeated until the desired concentration was obtained. This latter
procedure was not suitable for concentrating YPD medium because the
filter became quickly blocked. An attempt was made to remove these
blocking components by centrifugation but no pellet was obtained.
This effect was also observed with YOM medium but to a much lesser
extent, probably due to the simpler composition of this medium.
Each 5ml YPD sample was instead freeze dried and resuspended in
distilled water to a final volume of 400ul. lOul from each of the
above medium samples was boiled in sample buffer containing 2-
mercaptoethanol and analysed by SDS-PAGE (fig. 3.20A).
The cells, for some reason, grew more slowly in YOM LEU- medium
than expected so it is probably unwise to make any absolute
comparisons. The gel was not particularly clear and BLG was
detected only in the 48 hour lane from the YCM samples. Along with
the BLG control, it migrated faster than the BLG from the YPD
samples, which is difficult to see. This may be due to some
retardation effect caused by components in YPD medium. One thing
evident is that the BLG bands gradually disappeared in YPD samples.
Loss of plasmid over a period of time under non selective
conditions was expected, loss of protein was not. It is possible,
that once secreted into YPD medium, BLG is subjected to time
dependant denaturation and/or degradation or even conversion to
higher molecular mass species. This degradation may be due to the
release of proteases from dead cells, the amount of which will
increase the longer cells are maintained at stationary phase. No
similar conclusions can be drawn from YOM samples with this
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YPD YOM
Figure 3.20A SDS-PAGE of BLG secreted from yeast grown in YPD and
YOM. The boiling mix contained 2-mercaptoethanol.
YPD YOM
*
Figure 3.20B SDS-PAGE of dialysed medium samples.
2-mercaptoethanol was ommitted from the boiling mix.
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particular experiment. It was difficult to make a direct
comparison of yield of protein between cells grown in different
media. As already stated, cells grew more slowly in YOM LEU-
medium but should have reached a sufficiently high density after 48
hours to allow some comparable conclusions. BLG was difficult to
visualise on the gel owing to the effect of 2-mercaptoethano1 on an
already small concentration of protein, and to the high background
colouration in the YPD samples. The 16 hour YPD sample was
dialysed against distilled water and this time 15ul samples of this
and the 48 hour YOM sample was boiled in sample buffer without 2-
mercaptoethano1 and analysed by SDS-PAGE (fig. 3.20B).
BLG from both samples now ran at the same rate. Although the band
width was smaller, there appeared to be a much greater amount of
BLG present in the YPD lane compared to the YOM lane. This is
probably due to the higher cell density of the culture rather than
any increased efficiency of secretion.
It appears that YPD is a good growth medium for obtaining large
amounts of BLG. The gradual loss of protein and the increased loss
of plasmid copy number in cells grown in this medium may be offset
by the overall higher yield obtained and the shorter length of time
needed to grow cultures. It remains to be seen whether BLG will be
easily purified from such a complex mixture.
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3.9.2 Elution of BLG from DEAE cellulose by varying pH
A major problem associated with BLG purification involves its
initial concentration from large volumes of medium.
Ultrafiltration is time consuming but it may be possible to
concentrate the protein by binding it to ion exchange beads which
are gently stirred in the medium. The beads would then be allowed
to settle and in turn transferred to a column for elution. This
idea was tested on a small scale.
Bovine BLG was added to YPD medium at varying pH's to a
concentration of 250ug per ml. Samples (4ml) of each medium batch
were added to separate 5ml Falcon tubes containing 150mgs of DEAE
cellulose. Tubes were gently agitated for one minute and the
cellulose was gently centrifuged at lOOOrpm for 20 seconds. Samples
(lml) were removed from each supernatant and freeze dried and the
remaining supernatant discarded. The cellulose pellet was gently
resuspended in 4ml of 20mM sodium phosphate buffer at the
appropriate pH, mixed gently and centrifuged. This step was
repeated using fresh buffer and lml aliquots from each washing step
were freeze dried. The cellulose pellet was finally resuspended in
4ml of 20mM sodium phosphate buffer containing 200mM sodium
chloride, still maintaining the appropriate pH, and treated in the
same manner. All freeze dried samples were resuspended in lOOul of
distilled water from which 5ul was analysed by SDS-PAGE without 2-
































Figure 3.21 SDS-PAGE of bovine BLG eluted from DEAE cellulose by
varying pH.
A) Amount of BLG remaining in the medium after binding to DEAE
cellulose. Lane 1, concentration of BLG in the medium.
B) 20mM salt wash.
C) Step elution of BLG using 200mM salt.
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There are two advantages in using DEAE cellulose as an ion exchange
matrix. It shrinks very little when subjected to large variations
in salt concentration and it has no, or very few, gel filtration
properties. Figure 3.21A shows that BLG has efficiently bound to
the cellulose at all pH's when compared to the total amount of
protein present in the same volume (lane 1). Figure 3.21C shows
that, by comparing the band intensities with lane 1 of figure
3.21A, the protein has been efficiently eluted by the 200mM sodium
chloride step wash. BLG had previously been eluted from a DEAE
Sephadex column in a gradient ranging from 0 to lOOmM sodium
chloride. It was felt that, in this experiment, a single step wash
of 200mM sodium chloride should efficiently elute all BLG from the
matrix and therefore serve as the upper limit required to elute the
protein.
3.9.3 Elution of BLG from DEAE cellulose by varying salt
concentration■
A very similar experiment to the one above was set up to study the
elution of the protein at varying salt concentrations at a constant
pH.
Bovine BLG was added to YPD medium, at pH 6.5, and transferred to
Falcon tubes containing DEAE cellulose. Following mixing and
centrifugation, 1ml aliquots were freeze dried and the remaining
supernatant discarded. All pellets were washed twice in 20mM
sodium phophate buffer, at pH 6.5. The cellulose pellets were then
gentlly resuspended in 4ml of salt buffers of varying concentration
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and 1ml aliquots of each were freeze dried. The pellets were
finally subjected to a 200mM sodium chloride wash and aliquots were
treated in the same manner. Samples from all the washes were then
analysed by SDS-PAGE (figs. 3.22A and B).
Figure 3.22A once again showed the efficient binding of the protein
to the cellulose when comparing the total amount of BLG present in
the same volume (lane 8). Figure 3.22B, lanes 1 to 7, showed that
BLG is poorly eluted at salt concentrations of 75mM and lower, and
only eluted at reasonable levels at concentrations higher than
lOOmM. Correspondingly, the final wash at 200mM (lanes 8 to 14)
showed the amount of protein still bound to the cellulose decreased
in tubes that had previously been washed in consecutively higher
concentrations of salt.
These two experiments served as a rough guide to the conditions
required for the initial concentration and primary purification of
BLG from larger scale cultures. There were, however, limitations
to be kept in mind. The medium conditions used were not totally
analagous to those of a growing culture said the protein would be
present in the medium for a considerably longer period of time.
Extra constituents either secreted from the cells or present as a
result of cell death may have an effect on the protein outwith that
of degradation. In this experiment, BLG eluted over a broad range
of salt concentration. The mechanical force supplied by gentle
agitation might have induced the separation of the protein from the
matrix at a slightly lower salt concentration than would be
expected when the protein is eluted from a column.
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Figure 3.22 SDS-PAGE of bovine BLG eluted from DEAE cellulose, at
pH 6.5, by varying salt concentration.
A) Binding of BLG to DEAE cellulose
A-G. Amount of unbound BLG remaining in the medium
BLG. Concentration of BLG in the medium
B) Elution of BLG at varying Step elution of BLG remaining
concentrations of salt after the first salt wash
A. 20mM > A. 200mM
B. 50mM > B. 200mM
C. 7 5mM > C. 200mM
D. lOOmM > D. 200mM
E. 125mM > E. 200mM
F. 150mM > F. 200mM
G. 200mM > G. 200mM
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These experiments have shown that the binding of BLG to ion
exchange beads by gentle stirring is an efficient and rapid way of
isolating the protein from large volumes of medium. The protein
could either then be fractionated on a gradient, the upper limits
of which have been determined, or eluted in a single step to allow
further fractionation on another column.
3.10 Large scale purification of BLG from YPD medium.
Cells transformed with plasmid pMABLG were grown in four 100ml
cultures containing YOM LEU- medium. Each of these was subcultured
into 500ml of YPD and grown overnight. The cells were removed by
centrifugation and the pH of the medium was adjusted from pH 5.8 to
pH 6.5 with 1M sodium hydroxide. The medium was then added to two
500ml centrifuge bottles containing 50g of DEAE cellulose and
gently agitated for two to three minutes. The beads were separated
from the medium using a scintered glass funnel and then returned to
the centrifuge bottles. The whole process was repeated until all
the medium had been treated. The matrix was then washed in the
scintered glass funnel with 20mM sodium phosphate buffer, pH 6.5,
until the eluent ran clear. It was then transferred to a
centrifuge bottle and sodium phosphate buffer added to form a thick
slurry. This slurry was poured into a column to form a bed 5cm by
12cm. The cellulose was dark brown in colour showing it had bound
many constituents other than BLG. The column was washed in 20 mM
sodium phosphate buffer containing 200mM sodium chloride which
resulted in the migration of a dark brown band down the column.
Although the eluent was brown in colour, the column was also brown
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suggesting that it still retained a lot of material. This
procedure not only served as a concentration step but also allowed
the separation of many contaminants. The eluent was dialysed in
20mM sodium phosphate buffer, pH 6.5, and loaded onto a column of
fresh DEAE cellulose with a bed size of 2.2cm by 10cm. This column
was subsequently judged to be larger than necessary since
constituents in the loading eluent bound to the top 0.5cm of the
column. The column was then washed with a 70mM sodium chloride
step to remove contaminants at a salt concentration at which BLG
should remain bound, and then eluted in a 70mM to 350mM sodium
chloride gradient. This produced the elution profile in figure
3.23.
Material eluted by the 70raM sodium chloride wash was concentrated
by ultrafiltration and samples from this and from eluent fractions
from the gradient were analysed by SDS-PAGE. A small amount of BLG
was detected from the initial wash. This was not unexpected since
a small amount of protein was eluted in the small-scale experiment
at a similar salt concentration. No BLG was detected from
unconcentrated gradient fractions. It was assumed at this stage
that the apparent lack of protein was a result of its dilute
concentration. Material from the gradient eluted as a broad peak,
the top of which was off the scale of the chart recorder. An
attempt was made to increase resolution by using a smaller column
and a broader gradient. All eluent fractions from the above
gradient were pooled, concentrated and extensively dialysed in 20mM
sodium chloride buffer, pH 6.5. The supernatant was then loaded




Figure3.23 Elution profile from DEAE cellulose (I)
Bed size: 2.2 x 10cm
Eluent: 70mM wash followed by a 70 to 350mM sodium chloride
gradient in 20mM sodium phosphate buffer, pH 6.5
Figure 3.24 Elution profile from DEAE cellulose (||).
Bed size: 2.2 x 2.5cm .
Eluent: 50 to 250mM sodium chloride gradient in 20mM sodium
phosphate buffer, pH 6.5, followed by a 250mM salt
wash.
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a 50mM to 250mM sodium chloride gradient followed by a 250mM step
wash. The elution profile (fig. 3.24) showed that material eluted
from the column in two major peaks. SDS-PAGE of fractions from the
peak produced by the gradient showed very small amounts of protein
of a size comparable with that of BLG. Higher molecular mass bands
were present but they did not seem to correspond in size to higher
molecular mass BLG aggregates seen in previous experiments. No
bands corresponding to the size of BLG were detected from the step
wash.
The yield of protein from the columns was only a tiny fraction of
the expected amount. The cells were obviously synthesising BLG and
it was safe to assume that the protein had been bound by the ion
exchange beads. It was not clear what happened to the protein once
on the column. The small-scale experiments showed that BLG was
efficiently eluted in salt concentrations of 200mM. Therefore, it
was assumed that the initial 200mM salt wash had eluted the protein
along with a large amount of contaminants. Subsequent loading onto
a fresh column and elution with 70mm salt revealed the presence of
a small amount of BLG. This may have been a small subpopulation,
the rest of which may have been in varying degrees of aggregation
or degradation. It was possible that prolonged association with
contaminants on the column, known to have highly "sticky"
properties, or concentration by ultrafiltration with such
contaminants may have resulted in the formation of complexes, from
which the protein may not have been readily eluted. The columns
were not washed with high salt buffers to elute the protein. Even
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if this procedure had proved successful in eluting the protein, it
was decided that YPD medium was too complex to allow simple
purification of BLG.
3.11 Purification of BLG from YOM medium.
On this occasion a slightly different approach was chosen in which
the medium was pumped directly onto an ion exchange column.
A 3 litre culture was grown in YOM LEU- medium to stationary phase.
The cells were removed and the pH of the medium adjusted from 3.1
to 6.5. The medium was then pumped at 4°C directly onto a DEAE
cellulose column, 2.5cm by 5cm. Material absorbed on to the top
lcm of the column, judged by the slight yellow colour. The column
was then washed with a 250mM sodium chloride step and the eluent
was analysed by SDS-PAGE. Only a very small amount of BLG was
detected.
Once again, the protein failed to elute from the column in
significant amounts. YOM is much simpler in composition than YPD
and it was hoped that the factors responsible for the loss of
protein during isolation from YPD would either be eliminated or at
the very least be greatly reduced. It was also possible that the
elution problems were unrelated and that purification from two
different media produced different sets of problems. It was
unknown whether the protein existed in free association and only
formed complexes, not readily eluted from columns, when brought
into close proximity with high concentrations of medium
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constituents or whether such complexes formed readily even when
very dilute. Concentration by ultrafiltraion and by ion exchange
beads both had the effect of bringing BLG into close association
with medium constituents. Accumulation of such complexes on a
column to form even larger and more complicated aggregates may not
allow the protein to elute, at least at lower salt concentrations.
This may not be true for such precipitates remaining in a
supernatant. The very first large scale purification (page 83)
involving ultrafiltration followed by ion exchange chromatography
included an intermediate dialysis step in a weak salt buffer at a
higher pH. Subsequent elution from the column was easily
accomplished and at a salt concentration much lower than the steps
used above. The release of protein from complexes may require
lengthy dialysis incubations in buffers at the appropriate salt
concentration and pH. The precipitates on a column may have
complexed to such an extent as to have gone beyond the ability of
such an incubation to solubilise the protein. It was also possible
that the dialysis step had removed at least some of the low
molecular mass contaminants causing aggregation.
At the present stage, initial concentration of BLG from medium by
ion exchange methods had to be given up in favour of
ultrafiltration. This latter procedure also had the advantage of
allowing the protein to be detected before further purification.
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3.12 Purification of BLG by f.p.l.c.
A 1 litre culture of pMABLG-transformed cells was grown in YOM LEU-
medium. The cells were removed and the medium concentrated to 10ml
by ultrafiltration. A precipitate formed which was removed by
centrifugation and resuspended in 20mM sodium phosphate buffer, pH
6.5. The supernatant was dialysed against the same buffer.
Samples of the supernatant, before and after dialysis, and the
precipitate were analysed by SDS-PAGE (fig. 3.25). There was no
difference between supernatant samples before or after dialysis,
however, a considerable amount, probably greater than 50%, of the
BLG secreted into the medium was present in the precipitate.
The supernatant was concentrated from 10ml to 200ul during which a
small amount of precipitate was detected. The precipitate was
removed and the salt concentration of the supernatant altered to
150mM with sodium chloride. The sample was then fractionated on a
Superose 12 f.p.l.c. column and produced the elution profile in
figure 3.26.
SDS-PAGE showed that the end peak contained BLG of the correct
molecular mass (fig. 3.25, lane 6). It was puzzling to see four
major peaks in the elution profile resulting from the fractionation
of the dialysed supernatant sample that contained only two major
bands especially since the BLG peak was by no means the largest.
SDS-PAGE of the concentrated sample (fig. 3.25, lane 5) loaded onto
the column showed the presence of two extra bands not present in
the dialysed supernatant. This may leave one to conclude that
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Figure 3.25 SDS-PAGE of medium concentrated by ultrafiltration.
1) Precipitate resuspended and boiled in sample buffer.
2) BLG remaining in the supernatant prior to dialysis.
3) BLG remaining in the supernatant after dialysis.
4) Sample loaded onto the f.p.l.c. column. This sample consisted
of a 50 fold concentration of the supernatant shown in lane 3.
6) Sample from the end peak of the f.p.l.c. elution profile shown
in figure 3.26.
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+ shows the peak corresponding to BLG as determined by
SDS-PAGE
Figure 3.26 F.p.l.c. elution profile of concentrated medium
containing BLG.
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these extra bands represented aggregations of BLG and not
concentrated higher molecular mass contaminants since no such bands
existed in the dialysed supernatant of comparable intensity.
Although pure BLG was obtained at the end of the process, the yield
was very poor. Conditions would have to be altered to solubilise
the maximum amount of protein from the precipitate.
3.13 Altering concentrating conditions.
A 1 litre culture of cells transformed by pMABLG29 (mutant 29) was
grown and the medium concentrated to 11ml. A precipitate formed
during ultrafiltration. Three 1ml aliquots, containing suspended
precipitate, were removed and dialysed under differing conditions.
One was dialysed against 20mM sodium phosphate buffer, pH 6.5, at
room temperature, another was dialysed against growth medium, pH 3,
containing 350mM sodium chloride, at 4°C, and the last was dialysed
in the same conditions as the second but at room temperature.
After dialysis, precipitates were removed by centrifugation and
resuspended in boiling mix. Precipitate from the remaining 8ml was
removed and resuspended in boiling mix. The supernatant was
dialysed against the phosphate buffer. Treatment of the 8ml
fraction in this manner showed the amount of soluble BLG remaining
in the supernatant after ultrafiltration and could be used for a
comparison with the 1ml aliquots. After dialysis, equal size
aliquots from all supernatant samples along with equivilent amounts
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Figure 3.27 SDS-PAGE of BLG dialysed under varying conditions.
BLG
1. Precipitate, from the 8ml fraction.
2. Supernatant, from the 8ml fraction, dialysed against 20mM
sodium phosphate, pH 6.5, at RT.
3. Precipitate remaining after dialysis against 20mM sodium
phosphate, pH 6.5, at RT.
4. Supernatant fraction after dialysis against 20mM sodium
phosphate, pH 6.5, at RT.
5. Precipitate remaining after dialysis against medium containing
350mM sodium chloride, pH 3, at 4°C.
6. Supernatant fraction after dialysis against medium containing
350mM sodium chloride, pH 3, at 4°C.
7. Precipitate remaining after dialysis against medium containing
350mM sodium chloride, pH 3, at RT.
8. Supernatant fraction after dialysis against medium containing
350mM sodium chloride, pH 3, at RT.
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Dialysis at higher pH was the only procedure that solubilised the
protein to any great extent. No extra protein was solubilised in
medium samples containing high salt concentrations. Therefore, it
did not seem likely that addition of salt to medium prior to
concentration would inhibit the formation of precipitates.
All precipitate and supernatant samples were pooled and .dialysed in
50mM sodium phosphate buffer, pH 7, containing 150mM sodium
chloride, at room temperature. The precipitate formed by native
ovine BLG was also dialysed as well as concentrated medium from a
culture of pMABLG121 (mutant 121) transformed yeast. All three
samples were subsequently fractionated on a Superose 12 f.p.l.c.
column and produced the elution profiles shown in figures 3.28A, B
and C. It was interesting to note that the shape' of the profiles
was variable. Any effect on the profile by medium constituents
should remain reasonably constant, since the cells were all grown
in the same medium. Differing peak sizes may reflect variations in
abundance of certain sizes of BLG aggregates since only the peak
intensities were variable, not their retention times. SDS-PAGE
showed that the last major peak from each profile corresponded to
BIG of the correct size. The desired peaks from each sample were
pooled and refractionation showed that BLG could be purified to
homogeneity (fig. 3.29).
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Figure 3.28 F.p.l.c. elution profiles of A) dialysed native ovine BLG
precipitate, B) mutant 121, C) mutant 29.





Figure 3.29 F.p.l.c. elution profile of pure BLG. This figure
represents pooled fractions of the peak corresponding to BLG
from the previous fractionation of concentrated medium.
Subsequent reanalysis by f.p.l.c. showed the protein to be pure.
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3.14. Characterisation of BLG proteins.
3.14.1 Native PAGE of BLG
Concentrates of native BLG and mutants 29, 70 and 121 from samples
of media were analysed by native PAGE alongside bovine BLG (fig.
3.30A and B) . The bovine control was composed of two variants, A
and B. This reflected their differing mobilities under non
denaturing conditions. All three mutants migrated at the expected
rate with respect to the native ovine protein. Mutant 29
substituted an uncharged residue with a negatively charged one
resulting in the net gain of a negative charge. Mutant 70
substituted a positively charged residue with an uncharged one.
This substitution also resulted in the net gain of a negative
charge. As a result, both mutants migrated together ahead of the
native protein. Mutant 121 substituted one uncharged residue with
another resulting in no overall change to the net charge.
Therefore, it migrated alongside the native ovine protein.
3.14.2 Determination of molecular mass by f.p.l.c.
A Superose 12 column was individually calibrated at pH 7 with
proteins of known molecular mass and a graph of molecular mass
against retention time was plotted (fig. 3.31). The native ovine
protein and all secreted mutants were run on the column and the
retention times accurately noted. Using the equation derived from
the calibration curve, all ovine proteins were found to have a Mr
of 23,000. Monomers and dimers of BLG should have an approximate
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Figure 3.30 Native PAGE of BLG
A) 1,5 bovine BLG, mixture of A and B variants
2 native ovine BLG
3 mutant 29
4 mutant 70
B) 1 bovine BLG


















Mr of 18,000 and 36,000 respectively. It is well known that bovine
BLG exists as a dimer at physiological pH and there is evidence
that the ovine form also does [165]. The evidence here suggested
that all yeast secreted ovine proteins existed as monomers.
Although the experimental Mr was 23,000 this may result from an
inefficient separation of small proteins by the Superose 12 column.
Since there was no difference in mobility between yeast secreted
BLG and the bovine standard obtained from Sigma in denaturing gels,
it is possible that the increase in Mr results from some
noncovalent association with small medium derived components which
detach during the boiling step prior to SDS-PAGE. If this value is
correct, it is unclear why the ovine proteins, apart from mutant
29, should exist as monomers. It is possible that the proteins
have a subtly different conformation from the true protein however,
it is more likely that the protein may never be sufficiently
concentrated to allow dimerisation to occur [166]. There is also
the possiblity that the protein has been modified in some
undetermined way thus inhibiting dimerisation or even affecting the
structure as a whole. One possible modification is N-
glycosylation. Bovine BLG has a single Asn-X-Thr glycosylation
site at Asnl52. However, it has been shown that this site cannot
be glycosylated when X consists of a proline [167] and is supported
by the fact that BLG is not glycosylated in vivo. Ovine BLG has
the same site and SDS-PAGE has shown no difference in mobility
between the two proteins. One can conclude that the protein
secreted by yeast is not glycosylated. Studies on Cys mutant human
lysozymes secreted by yeast [168] showed the presence of mixed
disulphide derivatives between Cys95 and glutathione which affected
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enzyme activity. There is no suggestion that this has occurred in
secreted ovine proteins and is only mentioned as an example of an
unexpected spurious modification.
During these experiments, it was noticed that when fractions
containing the BLG peak were pooled and concentrated by
ultrafiltration, a precipitate formed. In future, another type of
ultrafiltration device may have to be used that induces less
denaturation of the protein. Ammonium sulphate precipitation is
another alternative but at the protein concentrations currently
available, recovery of protein by such means would be very
inefficient. The use of small ion exchange columns cannot be over
looked. Pure protein could be eluted from such a column in a
single step in a volume small enough to be useful.
3.14.3 Denaturation of ovine BLG in urea solutions at pH 2.8
Although the yield of protein recovered after f.p.l.c.
fractionation was low, it was possible to study the unfolding of
the protein in differing concentrations of urea and thus make a
comparison of its stability with bovine BLG. An estimation of
denaturation in increasing urea concentrations for bovine BLG was
obtained using c.d. spectroscopy. The value at 225nm obtained when
no urea was present was taken to represent the 100% native state
and hence the fully folded conformation of the protein. Subsequent

















Figure 3.32 Unfolding of bovine BLG in urea. 1 OOug samples of
BLG in 150mM potassium iodide, pH 2.83, were incubated in
various concentrations of urea for 15 min at 20°C prior to c.d.
analysis. Each urea concentration was repeated three times and
gave the error bars above.
= ovine BLG samples
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There was only enough "native" ovine protein to measure three
values. Although the points lay outside the error bars obtained
for the bovine protein, little, if anything, could be concluded
from the limited amount of information derived. The detector was
working at extreme sensitivities and so any error may have been
distorted. The protein may not have existed in its truly native
form. Apart from any distortions in structure provided by its
synthesis in yeast, concentration after f.p.l.c. fractionation in
the previous step produced a precipitate. Therefore, protein
remaining in solution may have already started down the road to
denaturation before addition of urea. Even if sufficient values
had been obtained, a true indication of its native structure would
only have been elucidated by comparison to an ovine standard.
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4.0 General discussion
A successful expression system for the synthesis and secretion of
ovine BLG was developed using plasmid pMA91 which contained the PGK
transcriptional control sequences, and the yeast strain AH22.
Earlier attempts using plasmids with the GAL1 and ADH1
transcriptional control sequences were unsuccessful. During
construction of these plasmids, the amount of noncoding DNA between
the promoters and the initiation of translation signal was kept to
a minimum since studies elswhere showed that the level of mouse
liver cytochrome P-450 PI expression in yeast increased as the
amount of upstream noncoding sequences of the original cDNA was
reduced [169]. The GAL1-BLG constructs contained no downstream
transcription termination signals. This would have resulted in the
synthesis of a larger mRNA that was probably not polyadenylated.
The processes controling mRNA stability are not clear at present.
There are cases where mRNAs lacking their poly(A)+ tails are
subject to degradation, presumably by exonucleases, and other cases
where it has been shown that larger mRNAs appear to be more
unstable [170]. However, studies have been carried out on the
expression of calf prochymosin in yeast using expression systems
with and without transcription termination signals [171]. The
plasmid without termination signals produced transcripts as large
as 3.8kb whereas the plasmid containing termination signals
produced a distinct transcript of around 1.75kb. Both expression
systems produced equal amounts of activatable prochymosin. It is
not clear whether the plasmids, containing the GAL1 promoter,
produced viable mRNA. However, problems of aberrant transcripts
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should not have arisen from the ADH-BLG construct which contained
the transcription termination signals for the yeast ADH1 gene. The
gene to be expressed from this ADH expression cassette requires the
presence of an ATG start codon and a translational termination
codon [159]. Both of these codons were supplied in the BLG insert
which should have resulted in the synthesis of a viable
polyadenylated transcript.
The problem may have been one of protein stability. All the BLG
proteins synthesised by plasmids with the GAL1 and the ADH1
promoters had a tetra-peptide joined onto the front of the leader
sequence. During the early stages of translation, yeast may not
have recognised the N-terminal portion of the polypeptide emerging
from the ribosome as a signal peptide and may not have directed the
mENA-ribosome complex to the rough endoplasmic reticulum. Although
there is no hard evidence regarding the presence of the signal
recognition particle observed in mammalian cells [172], yeast must
rely on similar machinery to specifically direct secretory proteins
to the rough endoplasmic reticulum. The formation of disulphide
bridges only occurs within the endoplasmic reticulum and is
catalysed by protein disulphide isomerase [173]. If translation
had proceeded in the cytoplasm, the signal peptide would not have
been excised and the correct disulphide bridges would not have
formed. The protein would not have folded properly under these
conditions and may have formed aggregates covalently linked by
disulphide bonds and/or it may have been degraded by proteolytic
enzymes. This scenario may seem plausible in light of the
expression of mutant 119. The lack of secretion of mutant 119
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suggests that it had also folded incorrectly and yet it was
detected in cellular extracts by Western analysis. The difference
may lie with the fact that this BLG had a functional signal peptide
and would have been translocated into the endoplasmic reticulum.
However, the amount of mutant 119 detected was very small and not
what might be expected from the intracellular accumulation of a
protein normally secreted. Eukaryote cells possess, polypeptide
chain binding proteins (PCBs), otherwise known as molecular
chaperones, that are thought to be involved in the folding of
nascent proteins and the unfolding of others prior to translocation
through membranes [174]. Binding of these PCBs to nascent
polypeptides is thought to limit the amount of nonspecific
aggregation that would otherwise occur. Programmed stepwise
release of these PCBs may allow proteins to fold correctly.
Several members of this family are induced during periods of cell
stress, eg. the hsp70 family, which may protect denatured proteins
from degradation or help them refold. It is possible that the lack
of secretion of mutant 119 results from interactions with PCBs.
Since it is not beneficial to the cell to accumulate wrongly folded
proteins in the endoplasmic reticulum, it is possible that mutant
119 was targeted for degradation. Studies involving the
degradation of newly synthesised T cell receptor subunits
identified two distinct degradative pathways, one lysosomal, the
other pre-Golgi which may either be part of, or closely associated
with, the endoplasmic reticulum [175]. The yeast cell vacuole
provides a similar role to the lysosome of higher eukaryotes and is
possibly the main site of protein degradation in yeast. There is
no information regarding an alternative endoplasmic reticulum
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related pathway in yeast. Even in the presence of these PCBs it is
also possible that prolonged accumulations induce the formation of
insoluble aggregates. Such insoluble aggregations were observed
when human lysozyme was expressed in yeast [176].
It is not clear at present how the substitution of Cysll9 with
serine affects the tertiary structure of BLG. One obvious feature
is the loss of the disulphide bridge with Cysl06. This fact alone
may be responsible for the altered stability of the protein.
However, during folding, protein disulphide isomerase may catalyse
the formation of a disulphide bond between Cysl06 and 121. It is
interesting to speculate that the formation of a disulphide bridge
between these two cysteine residues may be the cause of unstable
structural alterations. X-ray crystallography analysis has shown
that the disulphide bridge always forms between Cysl06 and Cysll9.
Formation of the alternative bond between Cysl06 and Cysl21 would
require a 10A shift between (3-strands G and H (fig. 4.0) which in
turn may cause regions of instability.
Since protein mobility in non reducing and reducing polyacrylamide
gels is affected by charge and conformation, it might be possible
to reveal structural alterations between the two Cysteine mutants
and the wild type not observed in SDS-PAGE. The migration of
mutant 119 would have to be detected by Western analysis due to the
contamination of cellular proteins. This experiment would not
reveal the number of disulphide bridges within each mutant.
Purification of mutant 119 by chromatographic means may prove
extremely difficult, especially if the protein is structurally
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Figure 4.0 Position of the disulphide bridge between G and H 6-
strands.
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unstable. One possible way of purifying sufficient amounts for
further analysis may rely on electroelution of the BLG band from a
polyacrylamide gel. It may then be possible to radiolabel free
sulphydryls in reducing and non reducing conditions with iodo[l-
14C]acetamide. Subsequent peptide digestion followed by 2D gel
electrophoresis should show a variation in the pattern obtained
under reducing and non reducing conditions. Any variations
observed in the mutant peptide patterns will be detected by
comparison with the pattern obtained from digestion of the wild
type protein. Under reducing conditions, mutants 119 and 121
should both show four radiolabelled peptides and the wild type
five. Under non reducing conditions, mutant 119 may show two (or
more) radiolabelled peptides, whereas, wild type should have only
one and mutant 121 should not have any.
However, apart from the possibilities discussed above, the problem
may have been one of detection. Even though all the earlier
expression studies were performed with small cultures, BLG was
detected by SDS-PAGE from similar size cultures using the PGK
expression system. The GAL1 and ADH1 promoters were known to be
functional since these promoters, obtained from the same source,
were used to express Drosophila ADH [160]. If BLG had formed
insoluble aggregates, such aggregates would associate with the
heavy membrane fraction following cell lysis and centrifugation.
As a result, no BLG would be detected in the soluble fraction by
SDS-PAGE.
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Further research regarding protein purification is required to
increase the yields of BLG. Even though initial yields were
disappointing, it is worth perservering in order to answer
important structural questions discussed in this thesis. Yields
may be increased by using different yeast strains eg. a strain that
carries the pmrl mutation can increase the efficiency of secretion
of heterologous proteins [179]. Future manipulation of the coding
sequence may also be facilitated by sucloning the PGR-BLG
expression unit into a phagemid like pVT102u. This would enable
expression studies and site-directed mutagenesis to be carried out
in the same plasmid without further subcloning procedures.
However, if yields of engineered BLG cannot be increased to satisfy
pharmaceutical requirements then other expression systems may have
to be considered. Bovine BLG has already been synthesised in
E.coli where it accounts for approximately 15% of the total cell
protein [180]. Most of the protein that is synthesised is found in
an insoluble form which is then solubilised in GuHCl. BLG isolated
in this manner appears to be acid stable suggesting that it
renatures into its native conformation. It may also be possible in
the future to generate transgenic cattle that can synthesise the
engineered form of the protein. Transgenic mice have already been
created that successfully express ovine BLG in their milk [181].
The use of such an expression system would supply almost limitless
amounts of protein that would be easy and cheap to purify.
-135b-
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